<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">97504</article-id><article-id pub-id-type="doi">10.7554/eLife.97504</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.97504.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Dynamic tracking of native precursors in adult mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Suying</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3947-8151</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>Sarah E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Haotian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ehnot</surname><given-names>Juliana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Seul K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jeffrey</surname><given-names>Greer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Menna</surname><given-names>Theresa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Purton</surname><given-names>Louise</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Hongzhe</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kurre</surname><given-names>Peter</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2747-0099</contrib-id><email>KURREP@email.chop.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02k3cxs74</institution-id><institution>Stem Cell Regulation Unit, St. Vincent's Institute of Medical Research</institution></institution-wrap><addr-line><named-content content-type="city">Fitzroy</named-content></addr-line><country>Australia</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Department of Medicine, The University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Parkville</named-content></addr-line><country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Queens University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>05</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP97504</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-04-02"><day>02</day><month>04</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-04-03"><day>03</day><month>04</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.04.02.587737"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-06-10"><day>10</day><month>06</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97504.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-11-15"><day>15</day><month>11</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97504.2"/></event></pub-history><permissions><copyright-statement>© 2024, Liu et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Liu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-97504-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-97504-figures-v1.pdf"/><abstract><p>Hematopoietic dysfunction has been associated with a reduction in the number of active precursors. However, precursor quantification at homeostasis and under diseased conditions is constrained by the scarcity of available methods. To address this issue, we optimized a method for quantifying a wide range of hematopoietic precursors. Assuming the random induction of a stable label in precursors following a binomial distribution, estimates depend on the inverse correlation between precursor numbers and the variance of precursor labeling among independent samples. Experimentally validated to cover the full dynamic range of hematopoietic precursors in mice (1–10<sup>5</sup>), we utilized this approach to demonstrate that thousands of precursors, which emerge after modest expansion during fetal-to-adult transition, contribute to native and perturbed hematopoiesis. We further estimated the number of precursors in a mouse model of Fanconi Anemia, showcasing how repopulation deficits can be classified as autologous (cell proliferation) and non-autologous (lack of precursor). Our results support an accessible and reliable approach for precursor quantification, emphasizing the contemporary perspective that native hematopoiesis is highly polyclonal.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hematopoiesis</kwd><kwd>clonal diversity</kwd><kwd>Fanconi Anemia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL150882</award-id><principal-award-recipient><name><surname>Kurre</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A revised analytical framework grounded in the principle of binomial distribution captures the full clonality and dynamic shifts of hematopoiesis throughout ontogeny.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Continuous self-renewal and differentiation of hematopoietic stem and progenitor cells (HSPCs) is fundamental to blood production. Even though rare cases exist where a single HSPC clone supports hematopoiesis, the HSPC population contributing to homeostatic hematopoiesis is usually highly polyclonal (<xref ref-type="bibr" rid="bib44">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Yamamoto et al., 2013</xref>). For example, the number of HSPCs actively participating in white blood cell production was estimated to range from 20,000 to 200,000 in humans (<xref ref-type="bibr" rid="bib28">Lee-Six et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Mitchell et al., 2022</xref>). Conversely, a decline in the number of active hematopoietic precursors has been linked to hematopoietic dysfunction. For example, in humans older than 70 years of age, hematopoietic dysfunction coincides with an abrupt reduction in the HSPCs population actively contributing to blood production (<xref ref-type="bibr" rid="bib33">Mitchell et al., 2022</xref>).</p><p>These observations underscore the association between a low number of active hematopoietic precursors and hematological function. Yet, few methods are suitable for quantifying active hematopoietic precursors in a native environment (<xref ref-type="bibr" rid="bib28">Lee-Six et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Mitchell et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Breivik, 1971</xref>; <xref ref-type="bibr" rid="bib7">Campbell et al., 2023</xref>; <xref ref-type="bibr" rid="bib46">Wallis et al., 1975</xref>; <xref ref-type="bibr" rid="bib45">Szilvassy et al., 1990</xref>). In mice, methods utilizing in situ barcodes often suffer from barcode homoplasy, preventing total precursor number estimation (<xref ref-type="bibr" rid="bib2">Bowling et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Pei et al., 2017</xref>). In humans, estimations based on somatic mutations and computational modeling carry a high degree of uncertainty (<xref ref-type="bibr" rid="bib28">Lee-Six et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Mitchell et al., 2022</xref>). The absence of precise precursor quantification methods in their natural environment hampers the study of precursor numbers across different conditions and their potential use as predictive functional markers.</p><p>In mice, the quantification of developmental hematopoietic precursors has been achieved using animals engineered with a <italic>Confetti</italic> cassette (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). This cassette can randomly recombine and express one of four fluorescence proteins (FPs, being RFP, CFP, YFP, or GFP) upon Cre induction, resulting in variability in Confetti expression pattern in mice that inversely correlates with precursor numbers (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). While suitable for developmental hematopoiesis, this method has limited linear range (50–2500), impeding its potential application to adult hematopoiesis or clonally restricted hematopoiesis. To measure hematopoietic precursors in various conditions, expansion of the detection range is desired.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The principle of inverse correlation between variance of FP% and precursor numbers.</title><p>(<bold>A</bold>) Schematic of the <italic>Confetti</italic> cassette at the mouse <italic>Rosa26</italic> locus. Sequences of four fluorescence protein are interspaced by loxP sites. Upon Cre-expression, the <italic>Confetti</italic> cassette will recombine and express one of the four fluorescence proteins. (<bold>B</bold>) The inverse relationship between variance of markers and precursor numbers. The distribution of FP% is determined in the progeny to estimate the number of precursors. (<bold>C</bold>) Workflow to validate the correlation formula between variance of FP% and precursor numbers by a two-color cell system. (<bold>D</bold>) Blue fluorescent protein (BFP) frequencies in wells seeded with 1–100,000 HL-60. Each dot represents a well. Two replicates were shown. Each replicate consists of at least 20 wells per seeded number. Error bars represent mean ± SD. (<bold>E</bold>) The standard deviation of BFP% in wells seeded with various numbers of HL-60. Error bars represent mean ± SD. <italic>N</italic> = 3 replicates. (<bold>F</bold>) The correlation between seeded numbers and standard deviation of BFP%. <italic>N</italic> = 3 replicates. (<bold>G</bold>) The correlation between seeded numbers and the numbers estimated with standard deviation of BFP% and <xref ref-type="disp-formula" rid="equ2">equation 2</xref>. <italic>N</italic> = 3 replicates except for seeded numbers 10<sup>6</sup> and 10<sup>7</sup> (gray circles). For 10<sup>6</sup> and 10<sup>7</sup>, <italic>N</italic> = 1 replicates. For (<bold>A–C</bold>), images were created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Establishing the correlation between variance of fluorescence protein (FP) and precursor numbers.</title><p>(<bold>A</bold>) The correlation between precursor numbers and coefficient of variances (CVs) of individual FP or all CVs (original correlation formula), replotted from <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>, <xref ref-type="fig" rid="fig1">Figure 1f</xref>. (<bold>B</bold>) FP<sub>mean</sub>% in a previously published dataset, replotted from <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>, <xref ref-type="fig" rid="fig1">Figure 1f</xref>. (<bold>C</bold>) The correlation between precursor numbers and standard deviation (<italic>σ</italic>) of individual FP, replotted from <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>. (<bold>D</bold>) The BFP% in HL-60 mix during 2 weeks of growth. (<bold>E</bold>) The effect of outliers on precursor number estimation. Left, BFP% in samples with/without outliers. Quartiles by Tukey method was shown. The outlier is highlighted by circle. Middle, standard deviation of BFP% with/without outliers. Right, estimated precursor numbers with/without outliers. (<bold>F</bold>) The changes of standard deviation when recorded events varied. ‘&amp;’ denotes the potential overestimated standard deviation due to low flow recorded events. (<bold>G</bold>) The variance of estimated precursor numbers when varying sample sizes were used. (<bold>H</bold>) The relative error of estimation as sample sizes increased. Each dot represents data from one seeded number. Error bars represent mean ± SD.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Data: original data for plotting <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Interestingly, the random induction of Confetti colors in HSPCs bears similarity with X-chromosome inactivation (XCI). In XCI, one of the X chromosomes is randomly inactivated in precursor cells, a process that adheres to a binomial distribution. Formula derivation from binomial distribution implies that a higher XCI variance among individuals correlates with a smaller number of precursors at the time of inactivation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). As XCI is faithfully maintained in the progeny, this correlation has been used to estimate precursor numbers from mature blood cells in human and mouse, leading to the discovery of the first mutation (Tet2) that contributes to clonal hematopoiesis (<xref ref-type="bibr" rid="bib46">Wallis et al., 1975</xref>; <xref ref-type="bibr" rid="bib4">Buescher et al., 1985</xref>; <xref ref-type="bibr" rid="bib1">Berger and Sturm, 1996</xref>; <xref ref-type="bibr" rid="bib6">Busque et al., 2012</xref>). Nonetheless, XCI occurs exclusively in females, limiting its applicability in males. Additionally, XCI takes place during early development when few precursors are present, resulting in low sensitivity in adulthood (<xref ref-type="bibr" rid="bib17">Gandini et al., 1968</xref>).</p><p>Building on insights from the <italic>Confetti</italic> mice and XCI studies, we investigated whether random induction of Confetti FPs in precursor cells can be similarly modeled by a binomial distribution, whereby the variance of FPs inversely correlates with precursor numbers. Based on this relationship, we asked if we could broaden the measurable range of precursor number, which would allow us to expand the existing correlation range.</p><p>Examining the premises of binomial distribution and setting some assumptions, we report that the random induction of FPs among a group of mice or cells can be modeled by a binomial distribution. Experimental validation establishes a broadened linear range, covering the full spectrum of precursor numbers (1–10<sup>5</sup>) and overcoming the prior range limit. We leverage this correlation to probe the number of hematopoietic precursors at homeostasis, post-myeloablation, during developmental expansion, and in a mouse model of inherited bone marrow (BM) failure.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Binomial distribution underlies the inverse linear correlation between FP% variance and the precursor numbers</title><p>To broaden the limited correlation range, we aimed to elucidate the mathematical relationship between variance and precursor numbers (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Inspired by XCI, we asked how the stochastic induction of Confetti FPs in precursors may satisfy the premises of binomial distribution (<xref ref-type="bibr" rid="bib32">Micklem et al., 1987</xref>; <xref ref-type="bibr" rid="bib22">Harrison et al., 1987</xref>). We found that when we assume the number of precursors remain the same for the condition tested, then induction of FPs meets the required premises: (1) the number of precursors, denoted as <italic>n</italic>, remains constant within a group of mice or cells; (2) each observation (e.g., each precursor) is independent; (3) each observation yields one of two outcomes (e.g., it signifies the presence or absence of RFP in a precursor); (4) the probability of success, represented as <italic>p</italic> (e.g., the likelihood of a precursor expressing RFP upon Confetti induction), remains consistent across all observations.</p><p>Should the induction of a FP adhere to a binomial distribution, precursor numbers can be estimated using the following equation:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mfrac><mml:mo>]</mml:mo></mml:mrow><mml:mtext> </mml:mtext><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf1"><mml:mover accent="true"><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> signifies the estimated number of precursors, <inline-formula><mml:math id="inf2"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> represents the estimated probability of a precursor being one given FP (e.g., <inline-formula><mml:math id="inf3"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula>), and <inline-formula><mml:math id="inf4"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula> denotes the estimated coefficient of variance (CV) of one given FP (e.g., <inline-formula><mml:math id="inf5"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></inline-formula>). CV is the standard deviation divided by the mean, utilized by the empirical correlation formula.</p><p>The equation proposes a direct linear relationship between the precursor number and the CVs of individual FPs, supporting the empirical correlation formula (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Indeed, by analyzing a published dataset providing precursor numbers and the corresponding distribution of FPs, we found that the correlation between <italic>n</italic> and individual CVs of FP exhibits superior fit (&gt;0.93), higher than the empirical correlation equation based on all three CVs (0.75) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Moreover, according to <xref ref-type="disp-formula" rid="equ1">equation 1</xref>, the <italic>y</italic>-intercept of correlation between precursor number and CV was influenced by FP<sub>mean</sub>%, while the slope was the same (−2) regardless of FP<sub>mean</sub>%. Given the unequal value of RFP<sub>mean</sub>%, CFP<sub>mean</sub>%, and YFP<sub>mean</sub>% in the published dataset, the correlation equations show significantly distinct <italic>y</italic>-intercepts (p &lt; 0.0001) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). In contrast, the slopes of these correlation equations were similar (p = 0.49, with all 95% confidence intervals encompassing −2, the theoretical value) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>).</p><p>In conclusion, the FP induction in precursor cells can be modeled by a binomial distribution with the assumption that precursor numbers are constant among a group of mice. This sets the mathematical basis for the inverse linear correlation between variance of FP% and the number of precursors.</p></sec><sec id="s2-2"><title>A broad range of precursor numbers correlates with variance of FP%</title><p>While the correlation formula derived from binomial distribution does not impose any range limitation, experimental errors may confound the measurement of variance. We next aimed to experimentally confirm this correlation. To streamline the calculation, we used standard deviation instead of CV to compute variance. The correlation between standard deviation and precursor numbers is expressed through the following equation:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mtext> </mml:mtext><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> denotes the estimated standard deviation of a given FP% (e.g., <inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>).</p><p>Given this equation, <inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> exhibits a linear and inverse correlation with <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>. Indeed, <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, and <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>Y</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> exhibited a linear and inverse correlation with <inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> in the published data (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>; <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>).</p><p>To simplify the validation, we used a two-color cell model HL-60 bearing one of the two FPs (BFP and GFP, wherein GFP represents non-BFP) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Although the <italic>Confetti</italic> cassette recombination can generate one of four colors, our estimation is based on a single given FP (e.g., a precursor expresses RFP or not), making this simplification justifiable.</p><p>We first proved that neither BFP nor GFP HL-60 cells had a competitive growth advantage over the other, ensuring that HL-60 progeny mirrored the seeding population (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). We next sorted one to 10<sup>7</sup> cells into individual wells and allowed them to proliferate for at least three generations before assessing BFP% at the end of the culture (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We focus on cell range up to 10<sup>5</sup> cells as 1.4 × 10<sup>5</sup> non-hematopoietic stem cell (HSC) LSK and 5.2 × 10<sup>3</sup> active HSCs were previously estimated in an adult female mouse, which corresponds to the highest possible precursor numbers in mice (<xref ref-type="bibr" rid="bib12">Cosgrove et al., 2021</xref>). We considered the survival rate of cells in wells receiving a single HL-60 cell (53–60%), to ensure the accuracy of the number of cells seeded.</p><p>Consistent with the proposed correlation, as seeded numbers increase, BFP% standard deviation decreases (<xref ref-type="fig" rid="fig1">Figure 1D, E</xref>). The variance of BFP% reveals an inverse correlation with the seeding numbers (<italic>R</italic><sup>2</sup> = 0.996) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). After normalizing for cell survival rates, the calculated numbers closely align with the expected numbers from one to 10<sup>6</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). We had anticipated that measurement of small variance in high-precursor numbers may be confounded by experimental errors. Indeed, at cell numbers larger than 10<sup>6</sup>, the standard deviation of BFP% and the expected number reached a plateau (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, gray circles). To ensure accurate measurement without confounding errors, we suggest 10<sup>5</sup> to be the upper limit for experimental measurement.</p></sec><sec id="s2-3"><title>Experimental practices for accurate precursor number measurement</title><p>It is crucial to ensure the accuracy of variance measured because variance of FP% is solely used for estimation. Based on the data from the two-color HL-60 model, we conclude that there are at least three experimental practices required for accurate cell estimates: (1) exclusion of outliers; (2) sufficient flow cytometry recorded events; (3) sufficient sample size per group. Both outliers and insufficient recorded events inaccurately inflate sample variance, leading to underestimation of precursor numbers (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E, F</xref>). We found that the minimum recorded events increase in tandem with the seeded number, in contrast to the reported 500-event threshold (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>; <xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>).</p><p>While having a small sample size per biological replicate is possible, the variability of estimates among replicates would be high (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). Practically, achieving a large sample size (&gt;20) is cumbersome in mice. To determine a feasible sample size for relatively accurate estimates, we resampled datapoints to calculate the variability reduction as sample size increases (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>). Our analyses reveal that five samples per group are sufficient to substantially minimize error, whereas an additional increase in sample size leads to marginal error reduction. We therefore use at least five mice per biological replicates for our precursor estimations.</p></sec><sec id="s2-4"><title>Inducible HSC-SCL-CreER<sup>T</sup>-targeted Confetti labeling in the active blood precursors at the adult stage</title><p>To label hematopoietic precursors and quantify their number in vivo, we considered the choice of Cre mouse line to be crossed with the <italic>Confetti</italic> mouse. Historically, hematopoietic precursors are thought to be HSCs capable of long-term repopulation. However, recent studies indicate that multipotent progenitors (MPPs) also contribute alongside HSCs in maintaining blood production (<xref ref-type="bibr" rid="bib16">Fanti et al., 2023</xref>; <xref ref-type="bibr" rid="bib36">Patel et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Schoedel et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Solomon et al., 2024</xref>). Hence, both HSCs and MPPs should be labeled.</p><p>Among Cre mouse lines capable of labeling HSCs and MPPs simultaneously at the adult stage (such as Rosa26<sup>CreERT2</sup>, Mx1-Cre, and HSC-SCL-CreER<sup>T</sup>), we chose HSC-SCL-CreER<sup>T</sup> because of its preference for labeling HSPCs (immunophenotypically defined as Lin<sup>−</sup>Sca-1<sup>+</sup>cKit<sup>+</sup> (LSK)) (<xref ref-type="bibr" rid="bib20">Göthert et al., 2005</xref>). To validate the specificity of HSC-SCL-CreER<sup>T</sup>, we generated mice possessing a single <italic>Confetti</italic> allele and homozygous HSC-SCL-CreER<sup>T</sup> alleles. We then examine Confetti expression 1 day after a 2-day tamoxifen administration. Consistent with prior reports of HSC-SCL-CreER<sup>T</sup> activity, we observed Confetti expression in the LSK population and T cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–E</xref>). Unexpectedly, Confetti expression was additionally detected in NK cells, CD41<sup>+</sup> cells, non-inflammatory monocytes (SSC-A<sup>low</sup>Ly6C<sup>-</sup>Ly6G<sup>-</sup>CD11b<sup>+</sup>), common myeloid progenitors (CMP, Lin<sup>−</sup>Sca-1<sup>−</sup>cKit<sup>+</sup>CD16/32<sup>−/low</sup>CD34<sup>+</sup>), and granulocyte–monocyte progenitors (GMP, Lin<sup>−</sup>Sca-1<sup>−</sup>cKit<sup>+</sup>CD16/32<sup>+</sup>CD34<sup>+</sup>) (<xref ref-type="bibr" rid="bib41">Schoedel et al., 2016</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D–G</xref>). Considering the relatively shorter lifespan of these cells compared to HSC/MPP, the labeling in these cells should minimally impact precursor calculations, especially with a chase period post-labeling. While the Confetti induction in the relatively long-lived T cells precludes estimation based on mature T cells, we conclude that HSC-SCL-CreER<sup>T</sup> remains a practical choice for labeling active hematopoietic precursors.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Transplantation of defined number of precursors.</title><p>(<bold>A</bold>) Representative flow plots showing Confetti induction by HSC-SCL-CreER<sup>T</sup> in the LSK population. (<bold>B</bold>) Schematic for transplantation of defined number of precursors. Briefly, 4 × 10<sup>6</sup> Confetti-induced WBM for ‘high-precursor number’ groups, or 0.25 × 10<sup>6</sup> WBM for ‘low-precursor number’ groups were transplanted into lethally irradiated recipient mice. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>C</bold>) RFP<sub>Conf</sub>% distribution in peripheral blood (PB) myeloid cells. Each dot represents one animal. Recipient sample size = 7–14 mice per replicate, <italic>N</italic> = 3 replicates per group. Error bars represent mean ± SD. (<bold>D</bold>) The precursor numbers of B cells, T cells, and myeloid cells in recipient mice. Dash lines mark the level of historically estimated transplantable clone numbers. Each dot represents a precursor number calculated from multiple mice. Error bars represent mean ± SD. (<bold>E</bold>) The correlation of precursor numbers calculated from RFP<sub>Conf</sub>%, YFP<sub>Conf</sub>%, or CFP<sub>Conf</sub>%. Each dot represents a precursor number calculated from multiple mice. (<bold>F</bold>) The precursor number of bone marrow (BM) MP and hematopoietic stem and progenitor cell (HSPC) in recipient mice. Dash lines represent historically estimated transplantable clone numbers. Each dot represents a precursor number calculated from multiple mice. Error bars represent mean ± SD. (<bold>G</bold>) The donor chimerism of recipient mice, and the CD45.2<sup>+</sup> chimerism differences between high- and low-precursor number groups. Each solid dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Recipient sample size = 7–14 mice per replicate, <italic>N</italic> = 3 replicates for each precursor number group. Two-way ANOVA for paired samples was performed. (<bold>H</bold>) The frequency of myeloid cells in the PB of recipients. Each dot represents one animal. Recipient sample size = 7–14 mice per replicate, <italic>N</italic> = 3 replicates for each precursor number group. Two-way ANOVA for paired samples was performed. ns, non-significant, *p &lt; 0.05, **p &lt; 0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The induction specificity of HSC-SCL-CreER<sup>T</sup>.</title><p>(<bold>A</bold>) Experiment schematic to examine the induction specificity of HSC-SCL-CreER<sup>T</sup>. <italic>N</italic> = 10 for induced animals, <italic>N</italic> = 3 for non-induced animals. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>B</bold>) Flow gating strategy for bone marrow (BM) hematopoietic stem and progenitor cell (HSPC) and MPs. (<bold>C</bold>) Confetti labeling in BM HSPCs. Error bars represent mean ± SD. (<bold>D</bold>) Flow gating strategy for BM lineage cells. (<bold>E</bold>) Confetti labeling in BM lineage cells. Error bars represent mean ± SD. (<bold>F</bold>) Flow gating strategy to examine spleen cells. (<bold>G</bold>) Confetti labeling in spleen cells. Error bars represent mean ± SD. See Methods and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for the detailed antibody, fluorophore and marker combination used for each cell type.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Data: original data for plotting <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Analysis of HSC-SCL-CreER<sup>T</sup> background Cre activity.</title><p>(<bold>A</bold>) Representative flow plot showing Confetti expression in peripheral blood (PB) T cells in 48- to 50-week-old <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals compared to an animal induced with 1-day tamoxifen treatment. (<bold>B</bold>) Quantification of RFP and YFP% in PB T cells. <italic>N</italic> = 8 for non-induced 48- to 50-week-old animals. (<bold>C</bold>) Representative flow plot for Confetti labeling in PB T cells post HSC-SCL-CreER<sup>T</sup>-mediated induction. (<bold>D</bold>) The level of CFP<sup>+</sup> and RFP<sup>+</sup> double positive cells in PB T cells of animals induced by HSC-SCL-CreER<sup>T</sup> compared to Vav-Cre/Confetti animals analyzed at the same age. <italic>N</italic> = 3 for Vav-Cre animals, <italic>N</italic> = 8 for HSC-SCL-CreER<sup>T</sup> animals.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Data: original data for plotting <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Variance of FP% inversely correlates with precursor numbers in vivo.</title><p>(<bold>A</bold>) The correlation between expected numbers and the estimated numbers calculated from FP% of precursors following Poisson distribution. See Methods for simulation details. (<bold>B</bold>) Flow gating strategy for peripheral blood (PB) B cell, T cell, and myeloid cell. See Methods and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for the detailed antibody, fluorophore, and marker combination used for each cell type. (<bold>C</bold>) RFP<sub>Conf</sub>% distribution in B cell and T cell. (<bold>D</bold>) YFP<sub>Conf</sub>% distribution in myeloid cell. (<bold>E</bold>) CFP<sub>Conf</sub>% distribution in myeloid cell. (<bold>F</bold>) RFP<sub>PB</sub>%, CFP<sub>PB</sub>%, YFP<sub>PB</sub>%, and Confetti% distribution in myeloid cells. (<bold>G</bold>) Linear correlation of PB precursor numbers calculated from RFP<sub>Conf</sub>%, RFP<sub>PB</sub>%, CFP<sub>PB</sub>%, YFP<sub>PB</sub>%, Confetti%, or RFP<sub>RFP+YFP</sub>%. Each dot represents a precursor number calculated from multiple mice. For (<bold>C–F</bold>), each dot represents one animal. Recipient sample size = 7–14 mice per replicate, <italic>N</italic> = 3 replicates per group. Error bars represent mean ± SD.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig2-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Bone marrow (BM) analysis for high- and low-precursor number groups.</title><p>(<bold>A</bold>) RFP<sub>Conf</sub>% distribution in BM hematopoietic stem and progenitor cells (HSPCs). Each dot represents one animal. (<bold>B</bold>) BM donor chimerism. (<bold>C</bold>) BM nucleated cell numbers. <italic>N</italic> = 15 mice for high-precursor number group, <italic>n</italic> = 14 for low-precursor number group. Unpaired <italic>t</italic> test was performed. (<bold>D</bold>) BM HSPC and MP frequency in donor CD45.2<sup>+</sup> population. Two-way ANOVA for paired samples was performed. For (<bold>B</bold>) and (<bold>D</bold>), each solid dot represents one animal; each outlined dot represents the average value of a replicate containing multiple animals. Except for (<bold>C</bold>), recipient sample size = 7–14 mice per replicate, <italic>N</italic> = 3 replicates per group. For all graphs, Error bars represent mean ± SD. ns, non-significant, *p &lt; 0.05.</p><p><supplementary-material id="fig2s4sdata1"><label>Figure 2—figure supplement 4—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig2-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig2-figsupp4-v1.tif"/></fig></fig-group><p>The stability of Confetti labeling after induction is required for binomial distribution. Therefore, the absence of background Cre activity after Confetti induction is critical. We determine the background Cre activity in <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals by two approaches: (1) detecting Confetti expression in non-induced animals; (2) identifying cells co-expressing two Confetti FPs months after tamoxifen induction due to cassette ‘flipping’ from background Cre activity. We observe no Confetti-expressing cells without tamoxifen treatment in mice up to 50 weeks old and minimal co-expression of two Confetti FPs in induced <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, B</xref>). Conversely, <italic>Vav-Cre/Confetti</italic> animals constitutively express Cre, resulting in ~15% cells co-expressing two Confetti colors in peripheral blood (PB) T cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C, D</xref>). Both lines of evidence support minimal Cre background activity in HSC-SCL-CreER<sup>T</sup> and its use as a Cre driver for precursor number calculation.</p></sec><sec id="s2-5"><title>The variance of FP% inversely correlates with precursor numbers in vivo</title><p>To ascertain the inverse correlation between variance of FP% and the number of hematopoietic precursors in vivo, we first investigate the variance of FP% in mice hosting various numbers of hematopoietic precursors. We generate these mice by non-competitively transplanting 0.25 × 10<sup>6</sup> or 4 × 10<sup>6</sup> induced CD45.2<sup>+</sup> <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> mouse BM cells into CD45.1<sup>+</sup> recipient mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Given the constant frequency of precursors in the donor BM (1/10<sup>5</sup>) and the varying doses of donor BM cells, these mice received approximately 2.5 (low-precursor number) or 40 (high-precursor number) precursors (<xref ref-type="bibr" rid="bib32">Micklem et al., 1987</xref>; <xref ref-type="bibr" rid="bib23">Harrison et al., 1988</xref>; <xref ref-type="bibr" rid="bib24">Harrison et al., 1990</xref>; <xref ref-type="bibr" rid="bib25">Harrison et al., 1993</xref>). While similar experiments transplanting defined numbers of precursors have been reported, the estimation for precursor numbers lower than 50 has not been explored.</p><p>Due to the scarcity of hematopoietic precursors in the BM, the precursor number seeded in recipients followed Poisson distribution instead of being constant, violating the premise (1) of binomial distribution. Nonetheless, our simulations show that the seeding number variation among recipient mice is relatively small, therefore the variance resulting from precursor number differences still dominates and inversely correlates with precursor numbers. A minor problem is that the estimated numbers are not at one-to-one ratio to expected numbers at low-precursor number range (&lt;10, see Methods) (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>).</p><p>As cells are not 100% labeled with Confetti, for clarity, we use ‘FP<sub>PB</sub>%’ or ‘FP<sub>BM</sub>%’ to represent the frequency of a given FP in the PB or BM, and use ‘FP<sub>Conf</sub>%’ to represent the frequency of a given FP in the Confetti<sup>+</sup> population. For total precursor number calculations, we normalize the number calculated from the Confetti-labeled population to Confetti labeling efficiency.</p><p>As expected, we observe higher RFP<sub>Conf</sub>% variance across all PB cell types in mice belonging to the ‘low-precursor number’ groups (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B, C</xref>). Since variance of any FP following a binomial distribution inversely correlates with precursor numbers, we also find higher CFP<sub>Conf</sub>% and YFP<sub>Conf</sub>% variance in the ‘low-precursor number’ groups (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3D, E</xref>). Following the same principle, we observe higher RFP<sub>PB</sub>%, CFP<sub>PB</sub>%, YFP<sub>PB</sub>%, and Confetti% variance in ‘low-precursor number’ mice (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3F</xref>).</p><p>Applying <xref ref-type="disp-formula" rid="equ2">equation 2</xref>, we find that the precursor numbers of B cells and myeloid cells are noticeably higher in the first 2 months than at 4 months post-transplantation, suggesting transient progenitor contributions at early timepoints (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). At 4 months post-transplantation, the estimated precursor numbers align with the expected values (in myeloid cells, 94 for ‘high-precursor number’ groups, three for ‘low-precursor number’ groups, <xref ref-type="fig" rid="fig2">Figure 2D</xref>). Again, for any FP following binomial distribution, variance of FP% inversely correlates with precursor numbers and thus can be leveraged to calculate precursor numbers (Methods). Since different FPs measure the same population of precursors, we expect the estimations from different FPs to be similar. Indeed, precursor numbers derived from RFP<sub>Conf</sub>% highly correlate with those estimated from YFP<sub>Conf</sub>% or CFP<sub>Conf</sub>% (<italic>R</italic><sup>2</sup> = 0.885 for CFP% in Confetti<sup>+</sup>, <italic>R</italic><sup>2</sup> = 0.769 for YFP% in Confetti<sup>+</sup>), as well as those from RFP<sub>PB</sub>%, YFP<sub>PB</sub>%, and CFP<sub>PB</sub>% (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3G</xref>).</p><p>Consistent with PB data, higher variance of RFP<sub>Conf</sub>% is also observed in the BM of ‘low-precursor number’ mice (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4A</xref>). The precursor numbers estimated from various BM HSPC subpopulations align well with each other and are consistent within the same group (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). However, in ‘high-precursor number’ groups, estimates from BM HSPCs are lower than those derived from PB myeloid cells (27 for BM HSPC, 94 for PB myeloid cells, <xref ref-type="fig" rid="fig2">Figure 2F</xref>). This discrepancy may reflect uneven seeding of precursors to the BM throughout the body after transplantation, and the fact that we only sample a part of the BM (femur, tibia, and pelvis) (<xref ref-type="bibr" rid="bib30">Li et al., 2023</xref>). In summary, we validate the inverse correlation between variance of FP% and precursor numbers in vivo. Moreover, the quantification of precursor numbers is feasible even for precursor numbers outside the empirical correlation range.</p></sec><sec id="s2-6"><title>Cell frequency measurements fail to reflect the differences in precursor numbers</title><p>Given that transplantation studies are performed non-competitively and the recipients are lethally irradiated, we expect to see minimal differences in donor chimerism between two groups, despite drastic differences in donor precursor numbers. Indeed, although we observe substantially lower donor chimerism in mice belonging to ‘low-precursor number’ groups during the first 2 months post-transplantation, the chimerism differences are very small by 4 months post-transplantation (5.5 ± 2.8%, <xref ref-type="fig" rid="fig2">Figure 2G</xref>). The initial differences in donor precursor numbers do not affect PB cell frequencies, except for the first month post-transplantation, when higher PB myeloid frequencies are observed in the ‘low-precursor number’ groups (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). This suggests myeloid cell production is enhanced when very few precursors are available after irradiation-mediated injury (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>In the BM, nucleated cell counts, donor chimerism, and HSPC frequencies are mostly similar regardless of donor precursor numbers, suggesting that even extremely low numbers of hematopoietic precursors can still effectively repopulate a non-competitive environment (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4B–D</xref>). Therefore, in cases where hematopoietic precursors expand or decline without competition, stem cell frequencies are less informative to study precursor activity. Measuring precursor numbers is more meaningful as low number of active precursors may be constrained by compensatory proliferation.</p></sec><sec id="s2-7"><title>Thousands of hematopoietic precursors contribute to native hematopoiesis</title><p>While the empirical formula, which measures 50–2500 precursors, supports quantification of precursors labeled at fetal stages, it may not be applicable to native hematopoiesis, when the total precursor number may exceed 2500. Having validated the feasibility for measuring precursor numbers in vivo by <italic>Confetti</italic> animals, we next sought to investigate the number of active precursors contributing to native hematopoiesis. In <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals, we opt to label a smaller portion of HSPCs with a 2-day treatment, despite the potential to label up to 60% HSPCs with Confetti (CFP + YFP + RFP) by 14-day tamoxifen treatment (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). This precautionary measure aims to mitigate potential toxicity arising from prolonged tamoxifen treatment.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Quantification of active hematopoietic precursor at steady state.</title><p>(<bold>A</bold>) Experiment schematic for Confetti induction in adult-induced animals. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>B</bold>) Confetti labeling in B cells, myeloid cells, and bone marrow (BM) hematopoietic stem and progenitor cells (HSPCs). Statistics for comparisons between labeling of month 7 and other months were shown. One-way ANOVA for paired samples was performed. (<bold>C</bold>) RFP<sub>Conf</sub>% in peripheral blood (PB) myeloid cells and BM HSPCs. Statistics for comparisons between labeling of month 7 and other months were shown. One-way ANOVA for paired samples was performed. (<bold>D</bold>) The number of myeloid precursors and the average precursor number from month 5 to 7. (<bold>E</bold>) The number of BM precursors. Paired permutation was performed. (<bold>F</bold>) The frequency-to-clone ratio of BM HSPCs. Paired permutation test was performed. Each solid dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Error bars represent mean ± SD. PB sample size = 14–22 mice per replicate; BM sample size = 8–10 mice per replicate; <italic>N</italic> = 4 replicates. ns, non-significant, *p &lt; 0.05, **p &lt; 0.001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Analysis of fluorescence protein (FP) induction in adult-induced animals.</title><p>(<bold>A</bold>) Confetti labeling in LSK after 14 days of tamoxifen treatment. <italic>N</italic> = 5 animals. Error bars represent mean ± SD. (<bold>B</bold>) CFP<sub>Conf</sub>% in peripheral blood (PB) myeloid cells. (<bold>C</bold>) CFP<sub>PB</sub>% in PB myeloid cells. (<bold>D</bold>) RFP<sub>RFP+YFP</sub>% in PB myeloid cells. (<bold>E</bold>) RFP<sub>PB</sub>% and YFP<sub>PB</sub>% in PB myeloid cells. (<bold>F</bold>) CFP<sub>Conf</sub>% in PB myeloid cells of fetal-induced animals (<bold>G</bold>) Bone marrow (BM) hematopoietic stem and progenitor cell (HSPC) frequencies. Error bars represent mean ± SD. For (<bold>B–E</bold>), sample size = 14–22 mice per replicate; for (<bold>F</bold>), sample size = 4–11 mice per replicate; for (<bold>G</bold>) sample size = 8–10 mice per replicate. For (<bold>B–E</bold>) and (<bold>G</bold>), <italic>N</italic> = 4 replicates. For (<bold>F</bold>), <italic>N</italic> = 5 replicates.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Unexpectedly, we observed a successive decrease of CFP<sub>Conf</sub>% and CFP<sub>PB</sub>% in some animals, which distort the distribution of CFP<sub>Conf</sub>% (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C</xref>). A similar decline is not observed in RFP<sub>Conf</sub>% or YFP<sub>Conf</sub>%, nor in RFP<sub>RFP+YFP</sub>% (calculated by RFP<sub>PB</sub>%/(RFP<sub>PB</sub>% + YFP<sub>PB</sub>%)) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D, E</xref>). A similar loss of CFP<sub>Conf</sub>% is neither observed in animals with Confetti induction during fetal development, suggesting a potential immune response to CFP in adult-induced animals (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). To circumvent this caveat, we decided to calculate precursor numbers solely based on the variance of RFP<sub>RFP+YFP</sub>%. Since only ~2% of myeloid cells are labeled with CFP, we reason that the decline of CFP in some animals is unlikely to affect the calculation of total precursor numbers based on other FPs, such as RFP<sub>RFP+YFP</sub>%. Moreover, in transplantation studies, precursor numbers calculated with variance of RFP<sub>RFP+YFP</sub>% linearly correlate with those calculated using variance of other FPs (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3G</xref>).</p><p>To further ensure accuracy, we focus on PB myeloid cells, as (1) Confetti labeling of T cells result from direct induction by HSC-SCL-CreER<sup>T</sup>, but not differentiation from HSPCs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>); (2) Confetti labeling (RFP and YFP) of B cells does not plateau at 7 months post-induction (<xref ref-type="fig" rid="fig3">Figure 3B</xref>); (3) myeloid cells are of shorter lifespan. In myeloid cells, we focus on precursor numbers after 4 months post-induction, when their labeling reaches a plateau (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The stability of average RFP<sub>RFP+YFP</sub>% suggests an equal contribution of RFP<sup>+</sup> and YFP<sup>+</sup> cells to the PB, a prerequisite for estimating precursor numbers from FP% distributions in the progenies (the myeloid cells) (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Like those in PB, the average RFP<sub>RFP+YFP</sub>% in BM HSPC subpopulations is also stable, supporting non-biased differentiation of RFP<sup>+</sup> and YFP<sup>+</sup> precursor cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>Fitting data to <xref ref-type="disp-formula" rid="equ2">equation 2</xref>, we estimate an average of 2667 precursors contributing to native myelopoiesis (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, average of numbers at 5–7 months post-induction). This number closely aligns with the clone number estimated by transposon-based barcodes statistic in granulocytes (831/30% = 2770) (<xref ref-type="bibr" rid="bib44">Sun et al., 2014</xref>).</p><p>The average precursor number calculated from PB myeloid cells at the time of BM analysis (1958) matches those calculated from BM myeloid progenitors (MP, Lin<sup>−</sup>Sca-1<sup>−</sup>cKit<sup>+</sup>) and HSPCs (1773 and 1917), but it is fivefold higher than that of LT-HSC (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Although LT-HSCs are thought to sustain steady-state hematopoiesis, recent studies suggest that ST-HSC and MPPs persist long term as primary contributors to adult hematopoiesis (<xref ref-type="bibr" rid="bib44">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Fanti et al., 2023</xref>; <xref ref-type="bibr" rid="bib41">Schoedel et al., 2016</xref>; <xref ref-type="bibr" rid="bib5">Busch et al., 2015</xref>). The observed discrepancy between the number of precursors contributing to LT-HSC and those contributing to MPPs indicates that at least some MPPs are not replaced by progenitors directly differentiated from LT-HSC at 7 months post-induction, affirming the persistence of MPPs (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Furthermore, the fact that PB myeloid and BM MP precursor numbers are closer to those of MPPs than LT-HSC confirms active and long-term (at least 7 months) contributions from MPPs to steady-state myelopoiesis.</p><p>Of note, the quantity of precursor does not necessarily correlate with the frequency of cell type in the BM. For example, the cell frequency of MPP2 (Lineage<sup>−</sup>cKit<sup>+</sup>Sca-1<sup>+</sup>Flk2<sup>−</sup>CD48<sup>+</sup>CD150<sup>+</sup>) in BM is very low, but MPP2 comprises a modest number of precursors, making its frequency-to-precursor-number ratio the lowest among the HSPC subtypes (<xref ref-type="fig" rid="fig3">Figure 3F</xref> and S6G). The frequency-to-precursor-number ratio reflects how well precursors of a particular type proliferate to expand their absolute cell count. The low frequency-to-precursor-number ratio of MPP2 suggests that it expands more poorly than other HSPC subtypes.</p><p>In summary, we detect thousands of hematopoietic precursors contributing to adult hematopoiesis. At the time of BM analysis, the number of PB myeloid precursors is comparable to those observed in BM MP and HSPCs.</p></sec><sec id="s2-8"><title>Precursor numbers determined by FP% variance confirm reduced clonality of progenitors after myeloablation</title><p>Myeloablation through 5-fluorouracil (5-FU) treatment depletes most actively cycling cells, forcing quiescent stem cells to proliferate (<xref ref-type="bibr" rid="bib47">Wilson et al., 2008</xref>). Previous studies have indicated a significant reduction in the number of clones detected within the BM c-Kit<sup>+</sup> population (consisting of MP and HSPC) following a single dose of 5-FU treatment (<xref ref-type="bibr" rid="bib2">Bowling et al., 2020</xref>). However, questions arise regarding whether this is an artifact stemming from potential under-sampling of the highly expanded c-Kit<sup>+</sup> population after 5-FU treatment by single-cell sequencing. Given the quantitative estimation of a wide range of precursor numbers through <xref ref-type="disp-formula" rid="equ2">equation 2</xref>, we aimed to investigate whether precursor numbers within progenitor populations indeed reduce 10 days post-5-FU treatment (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Number of precursors post-5-FU treatment and along developmental ontogeny.</title><p>(<bold>A</bold>) Experiment schematic for one-dose 5-FU treatment. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link></p><p>. (<bold>B</bold>) The number of bone marrow (BM) precursors post-5FU treatment. Permutation test was performed. For UT, sample size = 8–10 mice per replicate; <italic>N</italic> = 4 replicates; for 5-FU, sample size = 6–8 mice per replicate; <italic>N</italic> = 5 replicates. (<bold>C</bold>) Experiment schematic for Confetti induction at fetal stages. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>D</bold>) The Confetti labeling of B cells, T cells, and myeloid cells. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Sample size = 4–11 mice per replicate; <italic>N</italic> = 5 replicates. (<bold>E</bold>) The number of precursors in peripheral blood (PB) myeloid cells, B cells, and T cells. Permutation test was performed. For E14.5 and adult-induction, <italic>N</italic> = 4 replicates; for E11.5, <italic>n</italic> = 3 replicates. (<bold>F</bold>) The number of BM precursors. Each dot represents one precursor number. Permutation test was performed. For E14.5 and adult-induction, <italic>N</italic> = 4 replicates; for E11.5, <italic>N</italic> = 3 replicates. (<bold>G</bold>) The relative fold change increase of precursor numbers from fetal to adult stage, as well as fold change of CRU and cell counts. Error bars represent mean ± SD. ns, non-significant, *p &lt; 0.05, **p &lt;0.001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Analysis related to 5-FU treatment and Confetti fetal induction.</title><p>(<bold>A</bold>) Peripheral blood (PB) myeloid cells frequencies before 5-FU treatment and 10 days post-5-FU treatment. Dashed lines connect the values for the same replicate. Sample size = 6–8 mice per replicate, <italic>N</italic> = 5 replicates for 5-FU. Paired <italic>t</italic> test was performed. (<bold>B</bold>) The bone marrow (BM) hematopoietic stem and progenitor cell (HSPC) frequencies of UT and 5-FU-treated groups 10 days post-5-FU treatment. For UT, sample size = 8–10 mice per replicate, <italic>N</italic> = 4 replicates; for 5-FU, sample size = 6–8 mice per replicate, <italic>N</italic> = 5 replicates. (<bold>C</bold>) Confetti% in PB in E11.5-labeled animals. Dashed lines connect values for the same replicate. (<bold>D</bold>) The distribution of fluorescence proteins (FPs) in Confetti<sup>+</sup> population of B cells. Data showing average from all mice. <italic>N</italic> = 24–34 for E14.5, <italic>N</italic> = 7–24 for E11.5. Error bars represent mean ± SD. For (<bold>A–C</bold>), each solid dot represents one animal; each outlined dot represents the average value of a replicate containing multiple animals. ns, non-significant; *p &lt; 0.05, **p &lt; 0.001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To determine the precursor changes post-5-FU treatment, we use the animals described in <xref ref-type="fig" rid="fig3">Figure 3A</xref> as untreated (UT) benchmark cohort, which were collected at the same age. At 10 days post injection, the efficacy of 5-FU treatment is validated by lower PB myeloid cell frequency post-treatment and higher frequencies of BM progenitors compared to UT animals (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). The high-progenitor frequencies in the BM results from the depletion of cycling cells in the BM and the enhanced proliferation of HSPCs following 5-FU treatment.</p><p>Compared to UT animals, the precursor numbers of MP (including CMP, GMP, and MEP) and HSPC significantly decrease, confirming a reduction in clonality in the c-Kit<sup>+</sup> population (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; <xref ref-type="bibr" rid="bib2">Bowling et al., 2020</xref>). In contrast, the precursor numbers of LT-HSC do not show a decreasing trend. While transplantation studies support unchanged clonality of primitive stem cells after a single dose of 5-FU, a similar investigation in a native environment has not been conducted (<xref ref-type="bibr" rid="bib29">Lerner and Harrison, 1990</xref>). Our findings support the notion that native LT-HSC clonality remains unaltered following one-dose 5-FU treatment. Together, myeloablation treatment reinforces how the dynamics of precursor numbers can be tracked through Confetti pattern variations.</p></sec><sec id="s2-9"><title>Modest developmental expansion of active lifelong precursors</title><p>HSCs are thought to undergo substantial expansion in the fetal liver during fetal development (<xref ref-type="bibr" rid="bib35">Morrison et al., 1995</xref>; <xref ref-type="bibr" rid="bib15">Ema and Nakauchi, 2000</xref>; <xref ref-type="bibr" rid="bib40">Rybtsov et al., 2016</xref>). However, a recent study employing the empirical formula challenges this notion by quantifying endogenous lifelong hematopoietic precursors labeled at various developmental stages (<xref ref-type="bibr" rid="bib19">Ganuza et al., 2022</xref>). It revealed limited expansion of hematopoietic precursors during the fetal liver stage (from E10 to E15, 1.8- to 2.7-fold) as well as a gradual and moderate increase from the fetal liver to the post-natal stage (2.4- to 10-fold) (<xref ref-type="bibr" rid="bib19">Ganuza et al., 2022</xref>). Although intriguing, most post-natal measurements in this study fell outside the empirical linear range, leaving the genuine degree of post-natal precursor expansion uncertain. As our formula quantitatively assesses a wide range of precursor numbers, we set out to directly compare the numbers of precursor labeled at various development stages (E11.5 and E14.5, by one dose of tamoxifen; adult-stage, benchmark shown in in <xref ref-type="fig" rid="fig3">Figure 3A</xref>, all analyzed at the same age) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><p>For accuracy, we first examine the dynamics of Confetti labeling. In E14.5-induced animals, the Confetti labeling of T cells almost double from 1 to 4 months of age (4.7% at 1 month, 9.3% at 4 months), suggesting Confetti<sup>+</sup>-labeled precursors contribute more to post-natal T cells than non-labeled precursors (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Therefore, for T cells in E14.5-induced animals, we focus on precursor numbers generated after 3 months of age. The Confetti labeling for E11.5-induced animals remain stable for all timepoints examined (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>).</p><p>Similar to adult-induction, the distribution of average FP% is stable for fetal-induction, supporting equal proliferation of RFP<sup>+</sup> and YFP<sup>+</sup> cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Unlike adult-induction, fetal-labeled precursor numbers can be calculated with various combination of FP%, since the expression of CFP introduced at the fetal stages is stable (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Nonetheless, for consistency, all precursor numbers are calculated with variance of RFP<sub>RFP+YFP</sub>%, the one employed in adult-induction animals.</p><p>The resulting precursor number estimates for E11.5 and E14.5-labeled cohorts are similar in all PB cell types except at 2 and 3 months of age, echoing the previous study reporting limited lifelong precursor expansion in the fetal liver (<xref ref-type="fig" rid="fig4">Figure 4E</xref>; <xref ref-type="bibr" rid="bib19">Ganuza et al., 2022</xref>). Precursor numbers calculated from BM subpopulations are also comparable between the two timepoints (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Although E9.5-labeled clones are reported to seed non-uniformly across bones, the precursor numbers calculated from PB myeloid cells do not significantly differ from those calculated from BM MP and HSPC in E14.5-labeled animals (<xref ref-type="fig" rid="fig4">Figure 4F</xref>; <xref ref-type="bibr" rid="bib2">Bowling et al., 2020</xref>).</p><p>For comparison between fetal- and adult-induced animals, we focus on PB myeloid cells, as adult-induced animals have non-saturated labeling in B cells and non-HSPC-rooted Confetti labeling in T cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Here, we observe a relatively small increase of precursor numbers in adult-induced animals in PB and BM compared to those labeled at the fetal stage (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>). The increase between E11.5/E14.5- and adult-labeled precursors is less than 10-fold, similar to a previous report (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="bibr" rid="bib19">Ganuza et al., 2022</xref>).</p><p>Together, we confirm minimal to no expansion of lifelong precursors in the fetal liver stage and a minor expansion of expansion of lifelong precursors from fetal liver to adult stage.</p></sec><sec id="s2-10"><title><italic>Fancc<sup>−/−</sup></italic> mice have normal numbers of hematopoietic precursors at steady-state</title><p>Our approach provides an opportunity to investigate the number of active HSPC precursors in the native environment. To showcase precursor quantification in genetic mouse models, we focus on Fanconi Anemia (FA), the most common inherited BM failure syndrome (<xref ref-type="bibr" rid="bib9">Ceccaldi et al., 2012</xref>). Current FA mouse models exhibit mostly normal adult hematopoiesis at steady state but demonstrate reduced repopulation ability upon BM transplantation (<xref ref-type="bibr" rid="bib8">Carreau et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Haneline et al., 1999</xref>; <xref ref-type="bibr" rid="bib53">Zhang et al., 2010</xref>; <xref ref-type="bibr" rid="bib13">Du et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Dubois et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Zha et al., 2019</xref>). It remains unclear if their steady-state blood production is sustained by a reduced number of precursors, predisposing them to repopulation defects after transplantation.</p><p>To quantify precursor number in a mouse model of FA, we generate <italic>Fancc</italic><sup>+/+</sup>, <italic>Fancc</italic><sup>+/−</sup>, and <italic>Fancc</italic><sup>−/−</sup> mice with a single <italic>Confetti</italic> allele and homozygous <italic>HSC-SCL-CreER<sup>T</sup></italic> alleles (<italic>HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>+/+</sup></italic>, hereafter <italic>Fancc</italic><sup>+/+</sup><italic>; HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>+/−</sup></italic>, hereafter <italic>Fancc</italic><sup>+/−</sup><italic>; HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>−/−</sup></italic>, hereafter <italic>Fancc</italic><sup>−/−</sup>) (<xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref>). Consistent with previous literature, we observe similar PB cell frequencies and blood counts between <italic>Fancc</italic><sup>+/+</sup> and <italic>Fancc</italic><sup>−/−</sup> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–C</xref>; <xref ref-type="bibr" rid="bib51">Zha et al., 2019</xref>). BM nucleated cell counts, as well as HSPC and MP frequencies, are mostly identical, except for ST-HSC frequencies, which are significantly reduced in <italic>Fancc</italic><sup>−/−</sup> mice compared to <italic>Fancc</italic><sup>+/−</sup> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D, E</xref>).</p><p>To label hematopoietic precursors in FA animals, Confetti expression was induced at 2 months of age, and FP% was monitored over 7 months (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The absence of <italic>Fancc</italic> did not affect Confetti labeling efficiency, Confetti labeling dynamics or average FP% (RFP<sub>RFP+YFP</sub>%), suggesting precursor numbers in <italic>Fancc<sup>−/−</sup></italic> can be similarly calculated (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). As in previous adult-induction animals, RFP<sub>RFP+YFP</sub>% was used to estimate precursor numbers. The resulting myeloid and BM precursor numbers were comparable regardless of <italic>Fancc</italic> genotype, albeit <italic>Fancc</italic><sup>−/−</sup> mice had a slight reduction in HSPC precursor numbers (<xref ref-type="fig" rid="fig5">Figure 5C, D</xref>). These observations collectively suggest that a normal number of precursors sustains blood production in <italic>Fancc<sup>−/−</sup></italic> mice.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Precursor numbers in a mouse model of Fanconi Anemia (FA).</title><p>(<bold>A</bold>) Experimental workflow to generate <italic>Fancc</italic><sup>+/+</sup> and <italic>Fancc</italic><sup>−/−</sup> mice, induce Confetti expression and track precursor number dynamics. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>B</bold>) Confetti labeling in peripheral blood (PB) B cells and myeloid cells. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Dashed lines connect the values for the same replicate. (<bold>C</bold>) The number of PB myeloid precursors. (<bold>D</bold>) The number of bone marrow (BM) precursors. Permutation test was performed. (<bold>E</bold>) Experiment schematic for competitive transplantation. Image was created with <ext-link ext-link-type="uri" xlink:href="http://biorender.com/f96e500">BioRender.com/f96e500</ext-link>. (<bold>F</bold>) PB donor chimerism in recipient mice of young FA donors. Each dot represents one animal. Dashed lines connect the average donor chimerism of three replicates. For Fancc<sup>+/+</sup> or Fancc<sup>+/−</sup>, <italic>n</italic> = 10 per replicate, <italic>N</italic> = 3 replicates; for Fancc<sup>−/−</sup>, <italic>N</italic> = 7–9 per replicate, <italic>N</italic> = 3 replicates. Two-way ANOVA was performed. (<bold>G</bold>) The number of PB myeloid precursors post-transplantation of young FA donors. Dashed lines connect the average precursor numbers. Permutation test was performed. <italic>N</italic> = 3 for each group. (<bold>H</bold>) PB donor chimerism recipient mice of aging FA donor cells. Each dot represents one animal. Dashed lines connect the average donor chimerism of three replicates. For both genotype, <italic>N</italic> = 10 per replicate, <italic>N</italic> = 3 replicates. Two-way ANOVA was performed. (<bold>I</bold>) The number of PB B cell precursors post-transplantation of aging FA donors. Dashed lines connect the average precursor numbers. Permutation test was performed. <italic>N</italic> = 3 for each genotype. For (<bold>A–C</bold>), Fancc<sup>+/+</sup>, sample size = 11–17 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>+/−</sup>, sample size = 10–22 mice per replicate, <italic>N</italic> = 7 replicates; Fancc<sup>−/−</sup>, sample size = 9–17 mice per replicate, <italic>N</italic> = 4 replicates. For (<bold>D</bold>), Fancc<sup>+/+</sup>, sample size = 5–9 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>+/−</sup>, sample size = 6–12 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>−/−</sup>, sample size = 6–11 mice per replicate, <italic>N</italic> = 4 replicates. Error bars represent mean ± SD. nd, not determined; ns, non-significant; *p &lt; 0.05, **p &lt; 0.001. # represents lowest p value possible for permutation test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis of Fanconi Anemia (FA) mice at steady state.</title><p>(<bold>A</bold>) Peripheral blood (PB) myeloid cell frequencies. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. (<bold>B</bold>) PB B cell frequencies. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. (<bold>C</bold>) Complete blood count analysis. Each dot represents one animal. <italic>N</italic> = 13 for <italic>Fancc</italic><sup>+/+</sup>, <italic>N</italic> = 16 for <italic>Fancc</italic><sup>−/−</sup> mice. Unpaired <italic>t</italic> test was performed. (<bold>D</bold>) Bone marrow (BM) hematopoietic stem and progenitor cell (HSPC) frequencies. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. One-way ANOVA was performed. (<bold>E</bold>) BM nucleated cells counts. Each dot represents one animal. Unpaired <italic>t</italic> test was performed. <italic>N</italic> = 12 for <italic>Fancc</italic><sup>+/+</sup> and <italic>Fancc</italic><sup>−/−</sup> mice. (<bold>F</bold>) RFP<sub>RFP+YFP</sub>% in PB myeloid cells and B cells. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. For (<bold>A–B</bold>) and (<bold>F</bold>), Fancc<sup>+/+</sup>, sample size = 11–17 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>+/−</sup>, sample size = 10–22 mice per replicate, <italic>N</italic> = 7 replicates; Fancc<sup>−/−</sup>, sample size = 9–17 mice per replicate, <italic>N</italic> = 4 replicates. For (<bold>D</bold>), Fancc<sup>+/+</sup>, sample size = 5–9 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>+/−</sup>, sample size = 6–12 mice per replicate, <italic>N</italic> = 5 replicates; Fancc<sup>−/−</sup>, sample size = 6–11 mice per replicate, <italic>N</italic> = 4 replicates. Error bars represent mean ± SD. ns, non-significant; *p &lt; 0.05.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Analysis of Fanconi Anemia (FA) recipient mice.</title><p>(<bold>A</bold>) Young <italic>Fancc</italic> donor bone marrow (BM) hematopoietic stem and progenitor cell (HSPC) frequency analysis. <italic>N</italic> = 5 for Fancc<sup>+/+</sup> or Fancc<sup>+/−</sup>, <italic>N</italic> = 2 for Fancc<sup>−/−</sup>. (<bold>B</bold>) Donor chimerism in recipient BM of young <italic>Fancc</italic> donor. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Two-way ANOVA was performed. Recipient sample size = 7–10 mice per replicate, <italic>N</italic> = 3 replicates per group. (<bold>C</bold>) Number of peripheral blood (PB) B cell precursors in recipients of young FA donor. (<bold>D</bold>) Number of PB T cell precursors in recipients of young FA donor. (<bold>E</bold>) Number of BM HSPC precursors in recipients of young FA donor. (<bold>F</bold>) Aging <italic>Fancc</italic> donor BM HSPC frequency analysis. <italic>N</italic> = 3 for Fancc<sup>+/+</sup>, <italic>N</italic> = 3 for Fancc. (<bold>G</bold>) Number of PB myeloid cell precursors in recipients of aging FA donor. (<bold>H</bold>) Number of PB T cell precursors in recipients of aging FA donor. (<bold>I</bold>) Donor chimerism in recipient BM of aging <italic>Fancc</italic> donor. Each dot represents one animal. Each outlined dot represents the average value of a replicate containing multiple animals. Two-way ANOVA was performed. Recipient sample size = 7–10 mice per replicate, <italic>N</italic> = 3 replicates per group. (<bold>J</bold>) Number of BM HSPC precursors in recipients of aging FA donor. For (<bold>C–E</bold>), (<bold>G, H</bold>), and (<bold>J</bold>), <italic>N</italic> = 3 replicates per group; permutation test was performed; dashed lines connect the average precursor numbers. Error bars represent mean ± SD. nd, not determined; ns, non-significant; *p &lt; 0.05, **p &lt; 0.001. # represents lowest p value possible for permutation test.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Original data for plotting <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97504-fig5-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-fig5-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-11"><title>The number of <italic>Fancc<sup>−/−</sup></italic> precursors remains unchanged in mice transplanted with young donor cells</title><p>While <italic>Fancc</italic><sup>−/−</sup> mice have a similar number of precursors as their wildtype counterparts at homeostasis, it is unknown whether the reduced repopulation ability post-transplantation stems from diminished precursor numbers, reduced cell expansion, or a combination of both (<xref ref-type="bibr" rid="bib21">Haneline et al., 1999</xref>). To understand the underlying mechanism, we performed competitive transplantation using BM cells from 3-month-old Confetti-induced <italic>Fancc</italic><sup>+/+</sup>, <italic>Fancc</italic><sup>+/−</sup>, or <italic>Fancc</italic><sup>−/−</sup> mice along with CD45.1<sup>+</sup> competitor cells (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). Consistent with previous studies, recipient mice of <italic>Fancc</italic><sup>−/−</sup> cells show significantly lower donor chimerism in the PB and BM compared to those of <italic>Fancc</italic><sup>+/+</sup> or <italic>Fancc</italic><sup>+/−</sup> cells (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). Despite lower donor chimerism, PB and BM precursor numbers were unaffected in <italic>Fancc</italic><sup>−/−</sup> recipient mice (<xref ref-type="fig" rid="fig5">Figure 5G</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C–E</xref>). This suggests that reduced <italic>Fancc</italic><sup>−/−</sup> cell proliferation instead of fewer active precursors is likely the cause for the reduced repopulation capacity post-transplantation.</p></sec><sec id="s2-12"><title>Aging <italic>Fancc</italic><sup>−/−</sup> mice have reduced lymphoid hematopoietic precursors upon transplantation</title><p>Aging <italic>Fancc</italic><sup>−/−</sup> mice have been reported to develop hematologic neoplasms, resulting in decreased survival (<xref ref-type="bibr" rid="bib10">Cerabona et al., 2016</xref>). To determine if aging <italic>Fancc<sup>−/−</sup></italic> cells also maintain similar precursor numbers post-transplantation, we competitively transplanted BM cells from 9-month-old Confetti-induced <italic>Fancc<sup>+/+</sup></italic> or <italic>Fancc<sup>−/−</sup></italic> mice with CD45.1<sup>+</sup> competitor cells, a stage when aging <italic>Fancc<sup>−/−</sup></italic> mice start to show decreased survival (<xref ref-type="bibr" rid="bib10">Cerabona et al., 2016</xref>; <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2F</xref>).</p><p>The diminished repopulation ability of <italic>Fancc<sup>−/−</sup></italic> cells is reaffirmed by lower PB and BM chimerism (<xref ref-type="fig" rid="fig5">Figure 5H</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2I</xref>). While no differences in precursor numbers are noted during the initial post-transplantation period, a slight yet consistent reduction in lymphoid precursors is observed in <italic>Fancc<sup>−/−</sup></italic> recipient mice at 3–5 months post-transplantation (<xref ref-type="fig" rid="fig5">Figure 5I</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2G, H</xref>). Changes in precursor numbers in the BM of KO recipients are less clear, as we observed high variance in several HSPC subtypes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2J</xref>). Nonetheless, precursor numbers of MEP, LSK, and ST-HSC showed a consistent reduction. In conclusion, aging <italic>Fancc<sup>−/−</sup></italic> mice showed a modest but consistent loss of active PB lymphoid precursors post-transplantation, implying decreased lymphoid precursors additionally compromise repopulation capacity as <italic>Fancc<sup>−/−</sup></italic> mice age.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The polyclonal nature of endogenous hematopoiesis imposes methodological problems on a robust dynamic measurement. Inspired by the XCI studies, we successfully employed the correlation formula informed by binominal distribution to quantify precursor number in native hematopoiesis. Using <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals, we estimate thousands of precursors contributing to adult native hematopoiesis, a number comparable to the previous report (<xref ref-type="bibr" rid="bib44">Sun et al., 2014</xref>). This number results from a moderate increase during fetal-to-adult transition and respond dynamically to myeloablation by 5-FU. Applied to a mouse model of inherited BM failure (Fancc<sup>−/−</sup> mice), we detected normal precursor numbers at steady state and decreased lymphoid precursors upon transplantation of aging donors.</p><p>Although the linear relationship between variance of FP% and precursor numbers has been described, its measurable range has been limited (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Estimates outside this linear range may erroneously fall within it, making it challenging to distinguish accurate measurements within the range from inaccurate ones beyond it (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Based on binomial distribution, we expanded the measurable range to encompass the full spectrum of hematopoietic precursors in mice, minimizing the likelihood of inaccuracies. Furthermore, the linear correlation based on binomial distribution can accommodate any labeling system that follows the underlying premises, without the need for the multispectral <italic>Confetti</italic> cassette.</p><p>Having established a quantitative measurement, we were initially surprised by the moderate differences between fetal and adult precursors (<xref ref-type="bibr" rid="bib19">Ganuza et al., 2022</xref>). The maximum increase observed (7-fold observed in CMP) was substantially lower than the increase of competitive repopulation units (CRU) from E12 to E16 determined by limited dilution assays (~38-fold) (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), as well as the escalation from immunophenotype-defined HSPC counts (28- to 47-fold, from 3 to 5 × 10<sup>3</sup> at E14.5–1.4 × 10<sup>5</sup> at 2 months old) (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="bibr" rid="bib12">Cosgrove et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Ema and Nakauchi, 2000</xref>; <xref ref-type="bibr" rid="bib50">Young et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Mochizuki-Kashio et al., 2020</xref>). It is possible that we overestimated E11.5 precursors, as the numbers of lifelong E11.5 precursors were substantially higher (on average 753 PB myeloid precursor, 512 HSPC precursors) than the one to two repopulation units estimated with transplantation (<xref ref-type="bibr" rid="bib27">Kumaravelu et al., 2002</xref>). Nonetheless, our results were comparable to the ~870 hematopoietic cluster cells observed at E11.5 (<xref ref-type="bibr" rid="bib49">Yokomizo et al., 2022</xref>). We may have underestimated precursor numbers in adult-labeled animals, as most adult HSCs are quiescent (<xref ref-type="bibr" rid="bib47">Wilson et al., 2008</xref>). However, HSC precursor numbers did not increase after induced proliferation by one dose 5-FU treatment (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Therefore, we confirm the moderate precursor numbers difference between fetal and adult stages, emphasizing the analysis of hematopoiesis in a native environment. Future studies using different methods to investigate precursor activity locally should validate this result.</p><p>Novel methods tracing clones in situ offer new opportunities to study native hematopoiesis, yet most are challenging to apply in genetic models (<xref ref-type="bibr" rid="bib44">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib2">Bowling et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Pei et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Li et al., 2023</xref>; <xref ref-type="bibr" rid="bib39">Rodriguez-Fraticelli et al., 2018</xref>). Since only two mouse lines are required (<italic>Confetti</italic> and <italic>Cre</italic>, sometimes <italic>Cre</italic> is already included for conditional deletion of alleles), our approach is particularly convenient to study hematopoiesis in mouse models of genetic disorders. Applying precursor measurements to <italic>Fancc<sup>−/−</sup></italic> mice, we observe a minor decrease in precursor numbers after transplantation of aging donors. Although donor chimerism differences had been linked to differences in precursor numbers, reduced proliferation capacity may also contribute to reduced competitive repopulation capacity (<xref ref-type="bibr" rid="bib25">Harrison et al., 1993</xref>). In this case, definitive precursor number analysis is necessary to differentiate these possibilities.</p><p>Currently, concerns regarding clonal restriction in the context of FA gene therapy arises, as the engraftment of gene-corrected stem cells has yielded marginal clinical benefits (<xref ref-type="bibr" rid="bib38">Rio et al., 2019</xref>). For the first time, we demonstrate that FA cells maintain a normal precursor quantity post-transplantation, thereby disproving clonal attrition, including putative homing deficits post-transplantation as a cause in this model (<xref ref-type="bibr" rid="bib52">Zhang et al., 2008</xref>). However, it is imperative to acknowledge that the majority of murine models of FA, including the <italic>Fancc<sup>−/−</sup></italic> model utilized herein, do not recapitulate the pathophysiology observed in FA patients. Future investigations in other FA mice and studies leveraging FA patient-derived materials will be pivotal in corroborating and validating the findings presented here.</p><p>While we implemented a careful data processing procedure, one pitfall of our analyses was that we inferred precursor numbers from their progenies, assuming uniform and linear expansion from precursor to progenies. A recent study showed non-uniform precursor clone sizes, although the level of non-uniformity is low (<xref ref-type="bibr" rid="bib30">Li et al., 2023</xref>). In cases where the non-uniformity is high, according to mathematical modeling, we measured the major contributors to hematopoiesis (<xref ref-type="bibr" rid="bib43">Stone, 1983</xref>). Another potential caveat is that the relative contribution of Confetti-labeled precursors to blood production compared to non-labeled precursors remains unknown. Future studies using different Cre drivers should validate the precursor numbers for steady-state hematopoiesis.</p><p>In summary, we substantially broadened the applicable range of the correlation between variance of FP% and the precursor based on binomial distribution. We discovered thousands of precursors contributing to steady-state adult murine hematopoiesis and validated that fetal-to-adult precursor expansion is indeed limited. This analysis highlights active precursor numbers as an important metric in both normal and genetic mouse models.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Variance modeling with two-color HL-60</title><p>HL-60 cells were cultured with IMDM containing 20% fetal bovine serum (Gemini) and 5% penicillin–streptomycin (Gibco) and maintained at 1 × 10<sup>5</sup> and 1 × 10<sup>6</sup> cells/ml. Mycoplasma tests (Lonza) were performed routinely to rule out mycoplasma contamination. BFP-HL-60 and GFP-HL-60 were generated with lentivirus transduction of pGK-BFP (Genscript) and LeGO-V2 (a gift from Dr. Stefano Rivella lab). For seeding of one to 10,000 cells, sorting of HL-60 mixtures was performed using a BD FACS Aria III. For seeding of 100,000 cells, cell counts and dilution was used. After expansion, HL-60 cells were fixed with BD fixation buffer before Aurora (Cytek) or Cytoflex (Beckman Coulter) analysis.</p></sec><sec id="s4-2"><title>Mice</title><p>HSC-SCL-CreER<sup>T</sup> mice (<xref ref-type="bibr" rid="bib20">Göthert et al., 2005</xref>) were crossed with <italic>Confetti</italic> mice (<italic>Rosa26<sup>Brainbow2.1</sup></italic><sup>(<italic>Confetti</italic>)</sup>, full name B6.129P2-<italic>Gt(ROSA)26Sor<sup>tm1(CAG-Brainbow2.1)Cle</sup></italic>/J) to generate <italic>HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup></italic> (<italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic>) animals. <italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic> animals were crossed with <italic>Fancc</italic><sup>+/−</sup> mice (<xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref>) to generate <italic>HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>+/+</sup></italic> (<italic>Fancc<sup>+/+</sup></italic>), <italic>HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>+/−</sup></italic> (<italic>Fancc<sup>+/−</sup></italic>), and <italic>HSC-SCL-CreER<sup>T/T</sup>Rosa26<sup>+/Confetti</sup>Fancc<sup>−/−</sup></italic> (<italic>Fancc<sup>−/−</sup></italic>) mice. <italic>Vav-Cre</italic> was generously offered by Dr. Wei Tong (Children’s Hospital of Philadelphia). <italic>Vav-CreRosa26<sup>+/Confetti</sup></italic> animals were generated by crossing <italic>Vav-Cre</italic> with <italic>Rosa26<sup>Confetti</sup></italic> mice. All animals are in the B6 (CD45.2) strain background, unless otherwise stated. Six- to twelve-week-old females were used for timed pregnancies. Eight-week-old mice were used for adult Confetti induction. Both female and male mice were used (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>). Six- to eight-week-old female B6 CD45.1 mice (B6.SJL-<italic>Ptprc<sup>a</sup> Pepc<sup>b</sup></italic>/BoyJ, Jackson laboratories) were used as competitors and recipients for transplantation studies. All mice were maintained in the conventional small animal facility at the Children’s Hospital of Philadelphia (CHOP). All procedures involving animals were approved by the Institutional Animal Care and Use Committee at the Children’s Hospital of Philadelphia.</p></sec><sec id="s4-3"><title>Animal identification</title><p>Tail snip DNA was extracted using KAPA Express Extract Kit (Roche). Genotyping PCR was performed with HotStarTaq Master Mix (Qiagen) according to the manufacturer’s instruction. Genotyping primers used are summarized in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. To determine the zygosity of HSC-SCL-CreER<sup>T</sup>, qPCR was additionally performed with purified tail snip DNA using SYBR Green Universal Master Mix (Applied Biosystems).</p></sec><sec id="s4-4"><title>Animal procedures</title><p>For fetal induction, timed matings of HSC-SCL-CreER<sup>T/T</sup><italic>Rosa26<sup>Confetti/Confetti</sup></italic> mice and HSC-SCL-CreER<sup>T/T</sup><italic>Rosa26<sup>+/+</sup></italic> mice were set up. The mice were separated the next morning and noon of the day of separation was considered E0.5. Tamoxifen was delivered at 100 mg/kg to the dam orally at E11.5 or E14.5. Pups were C-sectioned and cross-fostered at E18.5 due to reported delivery difficulties caused by tamoxifen treatment (<xref ref-type="bibr" rid="bib31">Lizen et al., 2015</xref>). For mice used for defined (‘low’ versus ‘high’) number of transplantation (<xref ref-type="fig" rid="fig2">Figure 2</xref>), tamoxifen was delivered at 70 mg/kg orally once per day for 14 days at 8 weeks old. For adult-induction (<xref ref-type="fig" rid="fig3">Figure 3</xref>), tamoxifen was delivered at 70 mg/kg orally once per day for 2 days at 8-week-old. For one dose 5-fluorouracil (5-FU, Sigma) treatment, 5-FU was intraperitoneally injected once 10 days before BM harvest (37-week-old) at 150 mg/kg. To obtain PB for Confetti analysis, mice were anesthetized using isoflurane and retro-orbitally bled or submandibularly bled for <italic>Fancc<sup>−/−</sup></italic> mice with occasional congenital eye defects (<xref ref-type="bibr" rid="bib26">Joly et al., 2022</xref>) for 1 capillary of blood (50 µl). For PB counts, blood was collected in EDTA tubes using similar bleeding methods and was analyzed by the Translational Core Lab (Children’s Hospital of Philadelphia).</p></sec><sec id="s4-5"><title>BM sample processing</title><p>To collect BM cells, mice were euthanized by CO<sub>2</sub> inhalation. Tibia, femur and pelvis were dissected, and the BM cells were flushed with 26-gauge needles. The single-cell suspension generated with 18-gauge needles was then filtered through 70 µm strainers. Erythrocytes in the BM cells were hemolyzed by red blood cell lysis buffer before antibody staining or transplantation. For stem cell enrichment, BM cells were further lineage depleted using EasySep Mouse Hematopoietic Progenitor Cell Isolation Kit (STEMCELL Technologies).</p></sec><sec id="s4-6"><title>Flow cytometry analysis</title><p>PB and BM cells were analyzed using Aurora (Cytek) or BD FACS Aria III and the flow cytometry data were analyzed using FlowJo (Tree Star). The combinations of the following cell surface markers were used to define the PB populations: myeloid cells: CD11b<sup>+</sup> or Gr-1<sup>+</sup>; T-cell: CD3ε<sup>+</sup>; B-cell: B220<sup>+</sup>. The following combinations of cell surface markers were used to define the BM stem and progenitor cells (Lineage/Lin: CD11b, Gr-1, B220, CD3ε, Ter119): LTHSC: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>+</sup>Flk2<sup>−</sup>CD150<sup>+</sup>CD48<sup>−</sup>; MPP2: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>+</sup>Flk2<sup>−</sup>CD150<sup>+</sup>CD48<sup>+;</sup> MPP3: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>+</sup>Flk2<sup>−</sup>CD150<sup>−</sup>CD48<sup>+</sup>; MPP4: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>+</sup>Flk2<sup>+</sup>CD150<sup>−</sup>CD48<sup>+</sup>; STHSC: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>+</sup>Flk2<sup>−</sup>CD150<sup>−</sup>CD48<sup>−</sup>; MEP: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>−</sup>CD34<sup>−</sup>CD16/32<sup>−</sup>; CMP: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>−</sup>CD34<sup>mid</sup>CD16/32<sup>mid</sup>; GMP: Lin<sup>−</sup>c-Kit<sup>+</sup>Sca1<sup>−</sup>CD34<sup>+</sup>CD16/32<sup>+</sup>. For BM stem and progenitor cell analysis, DAPI (Biolegend) was used to distinguish dead cells. Representative examples of flow cytometry gating can be found in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>. The antibodies were used at optimized dilutions listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-7"><title>BM transplantation</title><p>The day before transplantation, female CD45.1 recipient mice were lethally irradiated (5.2 Gy × 2, 3 hr apart) using an X-ray irradiator (Precision). On the day of transplantation, BM cells from donor mice (CD45.2<sup>+</sup>) were collected under sterile conditions as described, RBC-lysed and counted for cell number. For <xref ref-type="fig" rid="fig2">Figure 2</xref> (transplantation of defined precursor numbers), donor mice were induced to express Confetti as described; donor BM cells were (non-competitively) injected into irradiated recipient mice; each matched high- and low- precursor number group received donor BM cells pooled from three to five mice. For transplantation of young <italic>Fancc</italic> mice, donor mice were induced to express Confetti at E14.5; 1.5 × 10<sup>6</sup> donor BM cells were mixed with 2.5 × 10<sup>5</sup> CD45.1 supporting BM cells and injected into irradiated recipient mice via tail vein. For transplantation of aging Fancc mice, donor mice were induced to express Confetti at 2 months of age; 2 × 10<sup>6</sup> donor BM cells were mixed with 5 × 10<sup>5</sup> CD45.1 supporting BM cells.</p></sec><sec id="s4-8"><title>Derivation of the correlation between variance of Confetti FP% and precursor numbers based on binomial distribution</title><p>When a random variable adheres to binomial distribution, studies have established that the following equation holds true:<disp-formula id="equ3"><mml:math id="m3"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>p</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p>where <italic>n</italic> signifies the number of precursors, <italic>p</italic> represents the probability of an individual being one of the FPs (e.g., RFP), and <italic>σ</italic><sup>2</sup> denotes the variance of specific FP% (e.g., <italic>σ</italic><sub>RFP%</sub><sup>2</sup>) (<xref ref-type="bibr" rid="bib46">Wallis et al., 1975</xref>). In experiments, <italic>p</italic> will be estimated with the average FP% in the Confetti<sup>+</sup> cells (e.g., RFP<sub>mean</sub>%), and <italic>σ</italic><sup>2</sup> will be estimated with the variance of FP% among a group of individual or mice (e.g., <inline-formula><mml:math id="inf14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>). Consequently, the estimation of precursors number <italic>n</italic> is calculated using the following equation:<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p>A logarithmic transformation can then be performed, allowing us to establish a linear relationship between the variance of FP% and the number of precursors:<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mtext> </mml:mtext><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>In a previous study (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>),<disp-formula id="equ6"><mml:math id="m6"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>%</mml:mi></mml:math></disp-formula></p><p>Therefore,<disp-formula id="equ7"><mml:math id="m7"><mml:mrow><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mi>n</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>F</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">%</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mfrac><mml:mo>]</mml:mo></mml:mrow><mml:mtext> </mml:mtext><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mi>lg</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mover><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="s4-9"><title>Resampling to determine sample size per replicate</title><p>FP% data generated from HL-60 was used for re-sampling. For each seeded number, FP% was resampled for different sample sizes from all the FP% with replacement. Variance of estimated <italic>n</italic> was then calculated by the standard deviation of the estimated precursor numbers generated from the same sample size. Relative error was determined by dividing variance of estimated <italic>n</italic> with the average of the estimated <italic>n</italic>. Refer to ‘varying well numbers.rmd’ for detailed R code.</p></sec><sec id="s4-10"><title>Simulation to determine the effect of varying FP<sub>mean</sub>% on correlation between variance of FP% and precursor numbers</title><p>Simulation of binomial distribution of varying FP<sub>mean</sub>% (probability of being a FP) was performed in R, generating corresponding FP% values used for variance calculation. The correlation between variance and precursor number <italic>n</italic> was then determined by linear correlation, and the slopes and intercepts were compared to each other. Refer to ‘Simulation of varying FPmean_percent.rmd’ for detailed R code.</p></sec><sec id="s4-11"><title>Simulation to determine the effect of precursor numbers following Poisson post-transplantation</title><p>Precursor numbers in individual samples were simulated to follow a Poisson distribution, where the mean of precursor numbers is the expected precursor numbers (expected <italic>n</italic>). The induction of an FP in each precursor was then simulated by random assignment, where probability of being an FP was set to be FP<sub>mean</sub>%. For each expected precursor numbers, variance of FP% among samples was then calculated, and <xref ref-type="disp-formula" rid="equ2">equation 2</xref> was used to estimate precursor numbers (estimated <italic>n</italic>). The correlation between expected <italic>n</italic> and estimated <italic>n</italic> was then plotted. Refer to ‘Double layer binomial simulation.rmd’ for detailed R code.</p></sec><sec id="s4-12"><title>Data processing and normalization</title><p>PB cell subset frequencies were normalized to the total % of myeloid cells, T cell, and B cell, to avoid an underestimate due to incomplete RBC lysis. For transplant animals, PB CD45.1<sup>+</sup>% and CD45.2<sup>+</sup>% are normalized to total CD45.1<sup>+</sup>% and CD45.2<sup>+</sup>% to avoid an underestimate due to incomplete RBC lysis. After normalization of cell frequencies, the sum of Confetti% and FP<sub>Conf</sub>% (diving FP<sub>PB</sub>% or FP<sub>BM</sub>% by sum of Confetti%) were then calculated for each cohort. At each step, potential outliers were removed based on Tukey method. The variance of FP<sub>Conf</sub>% and average FP<sub>Conf</sub>% are then fitted into <xref ref-type="disp-formula" rid="equ2">equation 2</xref> to calculate precursor numbers if sample size is at least five. The precursor number is then used to compared with the minimum flow cytometry recorded event of samples. If the estimated number is higher than the minimum flow count of samples, the sample with the minimum flow count will be excluded, and the calculation is performed again on the rest of samples. After exclusion, the resulting precursor number will be compared again with minimum flow count of samples, until it is lower than the minimum flow count or sample size is smaller than five.</p></sec><sec id="s4-13"><title>Statistical analysis</title><sec id="s4-13-1"><title>Statistical significance for precursor number estimates</title><p>As the distribution of precursor numbers is not predetermined, to compare mean precursor number differences between two conditions from a limited number of biological replicates, we employed permutation test. For unpaired permutation test, if there are three to five biological replicates per condition, the smallest p values possible are 0.05–0.004 (1/<inline-formula><mml:math id="inf15"><mml:mfenced separators="|"><mml:mrow><mml:mfrac linethickness="0pt"><mml:mrow><mml:mn>6</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math></inline-formula>–1/<inline-formula><mml:math id="inf16"><mml:mfenced separators="|"><mml:mrow><mml:mfrac linethickness="0pt"><mml:mrow><mml:mn>5</mml:mn></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math></inline-formula>). For paired permutation test, if there are three to five biological replicates per condition, the smallest p value possible are 0.125–0.03125 (1/2<sup>3</sup>–1/2<sup>5</sup>). Thus, for three to five biological replicates per condition, even though some of the p values may not reach the commonly used alpha level (0.05), it still represents substantial number differences. For those p values that were lowest possible but did not reach the alpha level, we specifically labeled with a ‘#’ in the figures and legends.</p></sec><sec id="s4-13-2"><title>Statistical analyses of other data</title><p>All other two-sample statistical analyses were performed using Student’s <italic>t</italic> test, if the sample was normally distributed, or Welch’s <italic>t</italic> test, when the sample was not normally distributed (<italic>F</italic> test). For multiple comparison, one- or two-way ANOVA was used.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology, Project administration</p></fn><fn fn-type="con" id="con3"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Antibody dilutions used for flow cytometry.</title></caption><media xlink:href="elife-97504-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The number of animals used for each figure/experiment.</title></caption><media xlink:href="elife-97504-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Genotyping primer sequences.</title></caption><media xlink:href="elife-97504-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-97504-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The original Confetti% measured in the PB and the BM and R code to analyze and reproduce all the results, numeric and figures can be found at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.8222789">https://doi.org/10.5281/zenodo.8222789</ext-link>. The re-analyzed data from a previous study can be found in the online version of papers (<xref ref-type="bibr" rid="bib18">Ganuza et al., 2017</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Suying</surname><given-names>L</given-names></name><name><surname>Sarah</surname><given-names>A</given-names></name><name><surname>Haotian</surname><given-names>E</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Greer</surname><given-names>J</given-names></name><name><surname>Theresa</surname><given-names>M</given-names></name><name><surname>Louise</surname><given-names>EP</given-names></name><name><surname>Hongzhe</surname><given-names>L</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>VariClone Resolves Population-level Clonal Structure in Native and Stress Hematopoiesis</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.8222789</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>Work was supported by R01-HL150882. We thank Florin Tuluc (CHOP Flow Cytometry Core) and Jessica Gucwa (Cytek bioscience) for assistance in flow cytometry; Kaosheng Lv (CHOP) for preparation of reagents; Zilu Zhou (Penn) for help in statistical analysis; Nancy Speck (Penn), Wei Tong (Penn), Julia Warren (Penn), Ding-wen (Roger) Chen (CHOP), Stephanie N Hurwitz (Penn), Hua Qing (Genentech), and Hui Chen (Penn) for in-depth discussion.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>CN</given-names></name><name><surname>Sturm</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Estimation of the number of hematopoietic precursor cells during fetal mouse development by covariance analysis</article-title><source>Blood</source><volume>88</volume><fpage>2502</fpage><lpage>2509</lpage><pub-id pub-id-type="doi">10.1182/blood.v88.7.2502.bloodjournal8872502</pub-id><pub-id pub-id-type="pmid">8839842</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowling</surname><given-names>S</given-names></name><name><surname>Sritharan</surname><given-names>D</given-names></name><name><surname>Osorio</surname><given-names>FG</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Cheung</surname><given-names>P</given-names></name><name><surname>Rodriguez-Fraticelli</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>WC</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>BE</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Hormoz</surname><given-names>S</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An Engineered CRISPR-Cas9 Mouse Line for Simultaneous Readout of Lineage Histories and Gene Expression Profiles in Single Cells</article-title><source>Cell</source><volume>181</volume><fpage>1410</fpage><lpage>1422</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.048</pub-id><pub-id pub-id-type="pmid">32413320</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breivik</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Haematopoietic stem cell content of murine bone marrow, spleen, and blood. Limiting dilution analysis of diffusion chamber cultures</article-title><source>Journal of Cellular Physiology</source><volume>78</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1002/jcp.1040780111</pub-id><pub-id pub-id-type="pmid">5111024</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buescher</surname><given-names>ES</given-names></name><name><surname>Alling</surname><given-names>DW</given-names></name><name><surname>Gallin</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool</article-title><source>The Journal of Clinical Investigation</source><volume>76</volume><fpage>1581</fpage><lpage>1584</lpage><pub-id pub-id-type="doi">10.1172/JCI112140</pub-id><pub-id pub-id-type="pmid">3863835</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Klapproth</surname><given-names>K</given-names></name><name><surname>Barile</surname><given-names>M</given-names></name><name><surname>Flossdorf</surname><given-names>M</given-names></name><name><surname>Holland-Letz</surname><given-names>T</given-names></name><name><surname>Schlenner</surname><given-names>SM</given-names></name><name><surname>Reth</surname><given-names>M</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fundamental properties of unperturbed haematopoiesis from stem cells in vivo</article-title><source>Nature</source><volume>518</volume><fpage>542</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/nature14242</pub-id><pub-id pub-id-type="pmid">25686605</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busque</surname><given-names>L</given-names></name><name><surname>Patel</surname><given-names>JP</given-names></name><name><surname>Figueroa</surname><given-names>ME</given-names></name><name><surname>Vasanthakumar</surname><given-names>A</given-names></name><name><surname>Provost</surname><given-names>S</given-names></name><name><surname>Hamilou</surname><given-names>Z</given-names></name><name><surname>Mollica</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Viale</surname><given-names>A</given-names></name><name><surname>Heguy</surname><given-names>A</given-names></name><name><surname>Hassimi</surname><given-names>M</given-names></name><name><surname>Socci</surname><given-names>N</given-names></name><name><surname>Bhatt</surname><given-names>PK</given-names></name><name><surname>Gonen</surname><given-names>M</given-names></name><name><surname>Mason</surname><given-names>CE</given-names></name><name><surname>Melnick</surname><given-names>A</given-names></name><name><surname>Godley</surname><given-names>LA</given-names></name><name><surname>Brennan</surname><given-names>CW</given-names></name><name><surname>Abdel-Wahab</surname><given-names>O</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis</article-title><source>Nature Genetics</source><volume>44</volume><fpage>1179</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1038/ng.2413</pub-id><pub-id pub-id-type="pmid">23001125</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>P</given-names></name><name><surname>Chapman</surname><given-names>MS</given-names></name><name><surname>Wilk</surname><given-names>M</given-names></name><name><surname>Boettcher</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>E</given-names></name><name><surname>Dawson</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>N</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Kovtonyuk</surname><given-names>L</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Caiado</surname><given-names>F</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>O’Neill</surname><given-names>L</given-names></name><name><surname>Kent</surname><given-names>D</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Nangalia</surname><given-names>J</given-names></name><name><surname>Manz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Clonal Dynamics after Allogeneic Haematopoietic Cell Transplantation Using Genome-Wide Somatic Mutations</article-title><source>Nature</source><volume>1</volume><elocation-id>2868644</elocation-id><pub-id pub-id-type="doi">10.21203/rs.3.rs-2868644/v1</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreau</surname><given-names>M</given-names></name><name><surname>Gan</surname><given-names>OI</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Doedens</surname><given-names>M</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name><name><surname>Buchwald</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability</article-title><source>Experimental Hematology</source><volume>27</volume><fpage>1667</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1016/s0301-472x(99)00102-2</pub-id><pub-id pub-id-type="pmid">10560914</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceccaldi</surname><given-names>R</given-names></name><name><surname>Parmar</surname><given-names>K</given-names></name><name><surname>Mouly</surname><given-names>E</given-names></name><name><surname>Delord</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Regairaz</surname><given-names>M</given-names></name><name><surname>Pla</surname><given-names>M</given-names></name><name><surname>Vasquez</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Q-S</given-names></name><name><surname>Pondarre</surname><given-names>C</given-names></name><name><surname>Peffault de Latour</surname><given-names>R</given-names></name><name><surname>Gluckman</surname><given-names>E</given-names></name><name><surname>Cavazzana-Calvo</surname><given-names>M</given-names></name><name><surname>Leblanc</surname><given-names>T</given-names></name><name><surname>Larghero</surname><given-names>J</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name><name><surname>Socié</surname><given-names>G</given-names></name><name><surname>D’Andrea</surname><given-names>AD</given-names></name><name><surname>Soulier</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells</article-title><source>Cell Stem Cell</source><volume>11</volume><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.05.013</pub-id><pub-id pub-id-type="pmid">22683204</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerabona</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Nalepa</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Leukemia and chromosomal instability in aged Fancc-/- mice</article-title><source>Experimental Hematology</source><volume>44</volume><fpage>352</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2016.01.009</pub-id><pub-id pub-id-type="pmid">26860989</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Tomkins</surname><given-names>DJ</given-names></name><name><surname>Auerbach</surname><given-names>W</given-names></name><name><surname>McKerlie</surname><given-names>C</given-names></name><name><surname>Youssoufian</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>O</given-names></name><name><surname>Carreau</surname><given-names>M</given-names></name><name><surname>Auerbach</surname><given-names>A</given-names></name><name><surname>Groves</surname><given-names>T</given-names></name><name><surname>Guidos</surname><given-names>CJ</given-names></name><name><surname>Freedman</surname><given-names>MH</given-names></name><name><surname>Cross</surname><given-names>J</given-names></name><name><surname>Percy</surname><given-names>DH</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name><name><surname>Buchwald</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia</article-title><source>Nature Genetics</source><volume>12</volume><fpage>448</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/ng0496-448</pub-id><pub-id pub-id-type="pmid">8630504</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosgrove</surname><given-names>J</given-names></name><name><surname>Hustin</surname><given-names>LSP</given-names></name><name><surname>de Boer</surname><given-names>RJ</given-names></name><name><surname>Perié</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hematopoiesis in numbers</article-title><source>Trends in Immunology</source><volume>42</volume><fpage>1100</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1016/j.it.2021.10.006</pub-id><pub-id pub-id-type="pmid">34742656</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>W</given-names></name><name><surname>Amarachintha</surname><given-names>S</given-names></name><name><surname>Erden</surname><given-names>O</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Meetei</surname><given-names>AR</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name><name><surname>Pang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fancb deficiency impairs hematopoietic stem cell function</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>18127</elocation-id><pub-id pub-id-type="doi">10.1038/srep18127</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname><given-names>EL</given-names></name><name><surname>Guitton-Sert</surname><given-names>L</given-names></name><name><surname>Béliveau</surname><given-names>M</given-names></name><name><surname>Parmar</surname><given-names>K</given-names></name><name><surname>Chagraoui</surname><given-names>J</given-names></name><name><surname>Vignard</surname><given-names>J</given-names></name><name><surname>Pauty</surname><given-names>J</given-names></name><name><surname>Caron</surname><given-names>M-C</given-names></name><name><surname>Coulombe</surname><given-names>Y</given-names></name><name><surname>Buisson</surname><given-names>R</given-names></name><name><surname>Jacquet</surname><given-names>K</given-names></name><name><surname>Gamblin</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Laprise</surname><given-names>P</given-names></name><name><surname>Lebel</surname><given-names>M</given-names></name><name><surname>Sauvageau</surname><given-names>G</given-names></name><name><surname>D d’Andrea</surname><given-names>A</given-names></name><name><surname>Masson</surname><given-names>J-Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A FANCI knockout mouse model reveals common and distinct functions for FANCI and FANCD2</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>7532</fpage><lpage>7547</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz514</pub-id><pub-id pub-id-type="pmid">31219578</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expansion of hematopoietic stem cells in the developing liver of a mouse embryo</article-title><source>Blood</source><volume>95</volume><fpage>2284</fpage><lpage>2288</lpage><pub-id pub-id-type="doi">10.1182/blood.v95.7.2284</pub-id><pub-id pub-id-type="pmid">10733497</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanti</surname><given-names>A-K</given-names></name><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Greco</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Cirovic</surname><given-names>B</given-names></name><name><surname>Shang</surname><given-names>F</given-names></name><name><surname>Nizharadze</surname><given-names>T</given-names></name><name><surname>Frank</surname><given-names>L</given-names></name><name><surname>Barile</surname><given-names>M</given-names></name><name><surname>Feyerabend</surname><given-names>TB</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Flt3- and Tie2-Cre tracing identifies regeneration in sepsis from multipotent progenitors but not hematopoietic stem cells</article-title><source>Cell Stem Cell</source><volume>30</volume><fpage>207</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.12.014</pub-id><pub-id pub-id-type="pmid">36652946</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandini</surname><given-names>E</given-names></name><name><surname>Gartler</surname><given-names>SM</given-names></name><name><surname>Angioni</surname><given-names>G</given-names></name><name><surname>Argiolas</surname><given-names>N</given-names></name><name><surname>Dell’Acqua</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>Developmental implications of multiple tissue studies in glucose-6-phosphate dehydrogenase-deficient heterozygotes</article-title><source>PNAS</source><volume>61</volume><fpage>945</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1073/pnas.61.3.945</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganuza</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>T</given-names></name><name><surname>Finkelstein</surname><given-names>D</given-names></name><name><surname>Chabot</surname><given-names>A</given-names></name><name><surname>Kang</surname><given-names>G</given-names></name><name><surname>McKinney-Freeman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lifelong haematopoiesis is established by hundreds of precursors throughout mammalian ontogeny</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>1153</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1038/ncb3607</pub-id><pub-id pub-id-type="pmid">28920953</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganuza</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>T</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Nevitt</surname><given-names>C</given-names></name><name><surname>Sánchez-Lanzas</surname><given-names>R</given-names></name><name><surname>Chabot</surname><given-names>A</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Kooienga</surname><given-names>E</given-names></name><name><surname>Caprio</surname><given-names>C</given-names></name><name><surname>Finkelstein</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>G</given-names></name><name><surname>Obeng</surname><given-names>E</given-names></name><name><surname>McKinney-Freeman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Murine foetal liver supports limited detectable expansion of life-long haematopoietic progenitors</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>1475</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-00999-5</pub-id><pub-id pub-id-type="pmid">36202972</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Göthert</surname><given-names>JR</given-names></name><name><surname>Gustin</surname><given-names>SE</given-names></name><name><surname>Hall</surname><given-names>MA</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Izon</surname><given-names>DJ</given-names></name><name><surname>Begley</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis</article-title><source>Blood</source><volume>105</volume><fpage>2724</fpage><lpage>2732</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-08-3037</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haneline</surname><given-names>LS</given-names></name><name><surname>Gobbett</surname><given-names>TA</given-names></name><name><surname>Ramani</surname><given-names>R</given-names></name><name><surname>Carreau</surname><given-names>M</given-names></name><name><surname>Buchwald</surname><given-names>M</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name><name><surname>Clapp</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Loss of FancC Function Results in Decreased Hematopoietic Stem Cell Repopulating Ability</article-title><source>Blood</source><volume>94</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1182/blood.V94.1.1.413k03_1_8</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DE</given-names></name><name><surname>Lerner</surname><given-names>C</given-names></name><name><surname>Hoppe</surname><given-names>PC</given-names></name><name><surname>Carlson</surname><given-names>GA</given-names></name><name><surname>Alling</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Large numbers of primitive stem cells are active simultaneously in aggregated embryo chimeric mice</article-title><source>Blood</source><volume>69</volume><fpage>773</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1182/blood.v69.3.773.773</pub-id><pub-id pub-id-type="pmid">3814815</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DE</given-names></name><name><surname>Astle</surname><given-names>CM</given-names></name><name><surname>Lerner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells</article-title><source>PNAS</source><volume>85</volume><fpage>822</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.3.822</pub-id><pub-id pub-id-type="pmid">2893377</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DE</given-names></name><name><surname>Stone</surname><given-names>M</given-names></name><name><surname>Astle</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Effects of transplantation on the primitive immunohematopoietic stem cell</article-title><source>The Journal of Experimental Medicine</source><volume>172</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1084/jem.172.2.431</pub-id><pub-id pub-id-type="pmid">1973702</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DE</given-names></name><name><surname>Jordan</surname><given-names>CT</given-names></name><name><surname>Zhong</surname><given-names>RK</given-names></name><name><surname>Astle</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations</article-title><source>Experimental Hematology</source><volume>21</volume><fpage>206</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">8425559</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joly</surname><given-names>S</given-names></name><name><surname>Rodriguez</surname><given-names>L</given-names></name><name><surname>Mdzomba</surname><given-names>JB</given-names></name><name><surname>Carreau</surname><given-names>M</given-names></name><name><surname>Pernet</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The ocular manifestations of Fanconi anemia in a genetic mouse model</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>60</volume><elocation-id>4738</elocation-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumaravelu</surname><given-names>P</given-names></name><name><surname>Hook</surname><given-names>L</given-names></name><name><surname>Morrison</surname><given-names>AM</given-names></name><name><surname>Ure</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Zuyev</surname><given-names>S</given-names></name><name><surname>Ansell</surname><given-names>J</given-names></name><name><surname>Medvinsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonad-mesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver</article-title><source>Development</source><volume>129</volume><fpage>4891</fpage><lpage>4899</lpage><pub-id pub-id-type="doi">10.1242/dev.129.21.4891</pub-id><pub-id pub-id-type="pmid">12397098</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee-Six</surname><given-names>H</given-names></name><name><surname>Øbro</surname><given-names>NF</given-names></name><name><surname>Shepherd</surname><given-names>MS</given-names></name><name><surname>Grossmann</surname><given-names>S</given-names></name><name><surname>Dawson</surname><given-names>K</given-names></name><name><surname>Belmonte</surname><given-names>M</given-names></name><name><surname>Osborne</surname><given-names>RJ</given-names></name><name><surname>Huntly</surname><given-names>BJP</given-names></name><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Anderson</surname><given-names>E</given-names></name><name><surname>O’Neill</surname><given-names>L</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Kent</surname><given-names>DG</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Population dynamics of normal human blood inferred from somatic mutations</article-title><source>Nature</source><volume>561</volume><fpage>473</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0497-0</pub-id><pub-id pub-id-type="pmid">30185910</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>C</given-names></name><name><surname>Harrison</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation</article-title><source>Experimental Hematology</source><volume>18</volume><fpage>114</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">2303103</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Bowling</surname><given-names>S</given-names></name><name><surname>McGeary</surname><given-names>SE</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Lemke</surname><given-names>B</given-names></name><name><surname>Alcedo</surname><given-names>K</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ferreira</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>S-W</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A mouse model with high clonal barcode diversity for joint lineage, transcriptomic, and epigenomic profiling in single cells</article-title><source>Cell</source><volume>186</volume><fpage>5183</fpage><lpage>5199</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.09.019</pub-id><pub-id pub-id-type="pmid">37852258</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizen</surname><given-names>B</given-names></name><name><surname>Claus</surname><given-names>M</given-names></name><name><surname>Jeannotte</surname><given-names>L</given-names></name><name><surname>Rijli</surname><given-names>FM</given-names></name><name><surname>Gofflot</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Perinatal induction of Cre recombination with tamoxifen</article-title><source>Transgenic Research</source><volume>24</volume><fpage>1065</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1007/s11248-015-9905-5</pub-id><pub-id pub-id-type="pmid">26395370</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micklem</surname><given-names>HS</given-names></name><name><surname>Lennon</surname><given-names>JE</given-names></name><name><surname>Ansell</surname><given-names>JD</given-names></name><name><surname>Gray</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Numbers and dispersion of repopulating hematopoietic cell clones in radiation chimeras as functions of injected cell dose</article-title><source>Experimental Hematology</source><volume>15</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">3469105</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>E</given-names></name><name><surname>Spencer Chapman</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>N</given-names></name><name><surname>Dawson</surname><given-names>KJ</given-names></name><name><surname>Mende</surname><given-names>N</given-names></name><name><surname>Calderbank</surname><given-names>EF</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Mitchell</surname><given-names>T</given-names></name><name><surname>Coorens</surname><given-names>THH</given-names></name><name><surname>Spencer</surname><given-names>DH</given-names></name><name><surname>Machado</surname><given-names>H</given-names></name><name><surname>Lee-Six</surname><given-names>H</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Hayler</surname><given-names>D</given-names></name><name><surname>Fabre</surname><given-names>MA</given-names></name><name><surname>Mahbubani</surname><given-names>K</given-names></name><name><surname>Abascal</surname><given-names>F</given-names></name><name><surname>Cagan</surname><given-names>A</given-names></name><name><surname>Vassiliou</surname><given-names>GS</given-names></name><name><surname>Baxter</surname><given-names>J</given-names></name><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Kent</surname><given-names>DG</given-names></name><name><surname>Chatterjee</surname><given-names>K</given-names></name><name><surname>Parsy</surname><given-names>KS</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Nangalia</surname><given-names>J</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Clonal dynamics of haematopoiesis across the human lifespan</article-title><source>Nature</source><volume>606</volume><fpage>343</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04786-y</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Mochizuki-Kashio</surname><given-names>M</given-names></name><name><surname>me Yoon</surname><given-names>Y</given-names></name><name><surname>Menna</surname><given-names>T</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name><name><surname>Kurre</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>FANCD2 Alleviates Physiologic Replication Stress in Fetal Liver HSC</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.09.30.320796</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Hemmati</surname><given-names>HD</given-names></name><name><surname>Wandycz</surname><given-names>AM</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The purification and characterization of fetal liver hematopoietic stem cells</article-title><source>PNAS</source><volume>92</volume><fpage>10302</fpage><lpage>10306</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.22.10302</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SH</given-names></name><name><surname>Christodoulou</surname><given-names>C</given-names></name><name><surname>Weinreb</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>da Rocha</surname><given-names>EL</given-names></name><name><surname>Pepe-Mooney</surname><given-names>BJ</given-names></name><name><surname>Bowling</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Osorio</surname><given-names>FG</given-names></name><name><surname>Daley</surname><given-names>GQ</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Lifelong multilineage contribution by embryonic-born blood progenitors</article-title><source>Nature</source><volume>606</volume><fpage>747</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04804-z</pub-id><pub-id pub-id-type="pmid">35705805</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>W</given-names></name><name><surname>Feyerabend</surname><given-names>TB</given-names></name><name><surname>Rössler</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Postrach</surname><given-names>D</given-names></name><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Rode</surname><given-names>I</given-names></name><name><surname>Klapproth</surname><given-names>K</given-names></name><name><surname>Dietlein</surname><given-names>N</given-names></name><name><surname>Quedenau</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Polylox barcoding reveals haematopoietic stem cell fates realized in vivo</article-title><source>Nature</source><volume>548</volume><fpage>456</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/nature23653</pub-id><pub-id pub-id-type="pmid">28813413</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rio</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Sánchez-Domínguez</surname><given-names>R</given-names></name><name><surname>Pujol</surname><given-names>RM</given-names></name><name><surname>Segovia</surname><given-names>JC</given-names></name><name><surname>Bogliolo</surname><given-names>M</given-names></name><name><surname>Merino</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Salgado</surname><given-names>R</given-names></name><name><surname>Lamana</surname><given-names>ML</given-names></name><name><surname>Yañez</surname><given-names>RM</given-names></name><name><surname>Casado</surname><given-names>JA</given-names></name><name><surname>Giménez</surname><given-names>Y</given-names></name><name><surname>Román-Rodríguez</surname><given-names>FJ</given-names></name><name><surname>Álvarez</surname><given-names>L</given-names></name><name><surname>Alberquilla</surname><given-names>O</given-names></name><name><surname>Raimbault</surname><given-names>A</given-names></name><name><surname>Guenechea</surname><given-names>G</given-names></name><name><surname>Lozano</surname><given-names>ML</given-names></name><name><surname>Cerrato</surname><given-names>L</given-names></name><name><surname>Hernando</surname><given-names>M</given-names></name><name><surname>Gálvez</surname><given-names>E</given-names></name><name><surname>Hladun</surname><given-names>R</given-names></name><name><surname>Giralt</surname><given-names>I</given-names></name><name><surname>Barquinero</surname><given-names>J</given-names></name><name><surname>Galy</surname><given-names>A</given-names></name><name><surname>García de Andoín</surname><given-names>N</given-names></name><name><surname>López</surname><given-names>R</given-names></name><name><surname>Catalá</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>JD</given-names></name><name><surname>Surrallés</surname><given-names>J</given-names></name><name><surname>Soulier</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Díaz de Heredia</surname><given-names>C</given-names></name><name><surname>Sevilla</surname><given-names>J</given-names></name><name><surname>Bueren</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1396</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0550-z</pub-id><pub-id pub-id-type="pmid">31501599</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Fraticelli</surname><given-names>AE</given-names></name><name><surname>Wolock</surname><given-names>SL</given-names></name><name><surname>Weinreb</surname><given-names>CS</given-names></name><name><surname>Panero</surname><given-names>R</given-names></name><name><surname>Patel</surname><given-names>SH</given-names></name><name><surname>Jankovic</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Calogero</surname><given-names>RA</given-names></name><name><surname>Klein</surname><given-names>AM</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Clonal analysis of lineage fate in native haematopoiesis</article-title><source>Nature</source><volume>553</volume><fpage>212</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/nature25168</pub-id><pub-id pub-id-type="pmid">29323290</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybtsov</surname><given-names>S</given-names></name><name><surname>Ivanovs</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Medvinsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Concealed expansion of immature precursors underpins acute burst of adult HSC activity in foetal liver</article-title><source>Development</source><volume>143</volume><fpage>1284</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1242/dev.131193</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoedel</surname><given-names>KB</given-names></name><name><surname>Morcos</surname><given-names>MNF</given-names></name><name><surname>Zerjatke</surname><given-names>T</given-names></name><name><surname>Roeder</surname><given-names>I</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Voehringer</surname><given-names>D</given-names></name><name><surname>Göthert</surname><given-names>JR</given-names></name><name><surname>Waskow</surname><given-names>C</given-names></name><name><surname>Roers</surname><given-names>A</given-names></name><name><surname>Gerbaulet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis</article-title><source>Blood</source><volume>128</volume><fpage>2285</fpage><lpage>2296</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-03-706010</pub-id><pub-id pub-id-type="pmid">27357698</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Govindarajah</surname><given-names>V</given-names></name><name><surname>Good</surname><given-names>S</given-names></name><name><surname>Arasu</surname><given-names>A</given-names></name><name><surname>Hinton</surname><given-names>EB</given-names></name><name><surname>Thakkar</surname><given-names>K</given-names></name><name><surname>Bartram</surname><given-names>J</given-names></name><name><surname>Filippi</surname><given-names>M-D</given-names></name><name><surname>Cancelas</surname><given-names>JA</given-names></name><name><surname>Salomonis</surname><given-names>N</given-names></name><name><surname>Grimes</surname><given-names>HL</given-names></name><name><surname>Reynaud</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Slow cycling and durable Flt3+ progenitors contribute to hematopoiesis under native conditions</article-title><source>The Journal of Experimental Medicine</source><volume>221</volume><elocation-id>e20231035</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20231035</pub-id><pub-id pub-id-type="pmid">37910046</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>A general statistical model for clone--tissue studies, using X-chromosome inactivation data</article-title><source>Biometrics</source><volume>39</volume><fpage>395</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">6626663</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><name><surname>Chapman</surname><given-names>B</given-names></name><name><surname>Johnnidis</surname><given-names>JB</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Ho</surname><given-names>Y-J</given-names></name><name><surname>Klein</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clonal dynamics of native haematopoiesis</article-title><source>Nature</source><volume>514</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature13824</pub-id><pub-id pub-id-type="pmid">25296256</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szilvassy</surname><given-names>SJ</given-names></name><name><surname>Humphries</surname><given-names>RK</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Eaves</surname><given-names>AC</given-names></name><name><surname>Eaves</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy</article-title><source>PNAS</source><volume>87</volume><fpage>8736</fpage><lpage>8740</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.22.8736</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>VJ</given-names></name><name><surname>Leuchars</surname><given-names>E</given-names></name><name><surname>Chwalinski</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>On the sparse seeding of bone marrow and thymus in radiation chimaeras</article-title><source>Transplantation</source><volume>19</volume><fpage>2</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1097/00007890-197501000-00002</pub-id><pub-id pub-id-type="pmid">1118887</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Oser</surname><given-names>G</given-names></name><name><surname>van der Wath</surname><given-names>RC</given-names></name><name><surname>Blanco-Bose</surname><given-names>W</given-names></name><name><surname>Jaworski</surname><given-names>M</given-names></name><name><surname>Offner</surname><given-names>S</given-names></name><name><surname>Dunant</surname><given-names>CF</given-names></name><name><surname>Eshkind</surname><given-names>L</given-names></name><name><surname>Bockamp</surname><given-names>E</given-names></name><name><surname>Lió</surname><given-names>P</given-names></name><name><surname>Macdonald</surname><given-names>HR</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair</article-title><source>Cell</source><volume>135</volume><fpage>1118</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.10.048</pub-id><pub-id pub-id-type="pmid">19062086</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>R</given-names></name><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Ooehara</surname><given-names>J</given-names></name><name><surname>Hamanaka</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>M</given-names></name><name><surname>Rudolph</surname><given-names>KL</given-names></name><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells</article-title><source>Cell</source><volume>154</volume><fpage>1112</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.08.007</pub-id><pub-id pub-id-type="pmid">23993099</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokomizo</surname><given-names>T</given-names></name><name><surname>Ideue</surname><given-names>T</given-names></name><name><surname>Morino-Koga</surname><given-names>S</given-names></name><name><surname>Tham</surname><given-names>CY</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>M</given-names></name><name><surname>Araki</surname><given-names>K</given-names></name><name><surname>Osato</surname><given-names>M</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Independent origins of fetal liver haematopoietic stem and progenitor cells</article-title><source>Nature</source><volume>609</volume><fpage>779</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05203-0</pub-id><pub-id pub-id-type="pmid">36104564</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>I-C</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Andricovich</surname><given-names>J</given-names></name><name><surname>Chuang</surname><given-names>S-T</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Tzatsos</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>R-C</given-names></name><name><surname>Wu</surname><given-names>M-Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Differentiation of fetal hematopoietic stem cells requires ARID4B to restrict autocrine KITLG/KIT-Src signaling</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>110036</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.110036</pub-id><pub-id pub-id-type="pmid">34818550</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zha</surname><given-names>J</given-names></name><name><surname>Kunselman</surname><given-names>L</given-names></name><name><surname>Fan</surname><given-names>JM</given-names></name><name><surname>Olson</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bone marrow niches of germline FANCC/FANCG deficient mice enable efficient and durable engraftment of hematopoietic stem cells after transplantation</article-title><source>Haematologica</source><volume>104</volume><fpage>e284</fpage><lpage>e287</lpage><pub-id pub-id-type="doi">10.3324/haematol.2018.202143</pub-id><pub-id pub-id-type="pmid">30679321</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Shang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Murphy</surname><given-names>K</given-names></name><name><surname>Kirby</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>P</given-names></name><name><surname>Reeves</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>FO</given-names></name><name><surname>Williams</surname><given-names>DA</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Pang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group A</article-title><source>Blood</source><volume>112</volume><fpage>1683</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-03-147090</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q-S</given-names></name><name><surname>Marquez-Loza</surname><given-names>L</given-names></name><name><surname>Eaton</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AW</given-names></name><name><surname>Goldman</surname><given-names>DC</given-names></name><name><surname>Anur</surname><given-names>P</given-names></name><name><surname>Watanabe-Smith</surname><given-names>K</given-names></name><name><surname>Rathbun</surname><given-names>RK</given-names></name><name><surname>Fleming</surname><given-names>WH</given-names></name><name><surname>Bagby</surname><given-names>GC</given-names></name><name><surname>Grompe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol</article-title><source>Blood</source><volume>116</volume><fpage>5140</fpage><lpage>5148</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-278226</pub-id><pub-id pub-id-type="pmid">20826722</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, B6)</td><td align="left" valign="bottom">CD45.1</td><td align="left" valign="bottom">Jackson laboratories</td><td align="left" valign="bottom">B6.SJL-<italic>Ptprc<sup>a</sup> Pepc<sup>b</sup></italic>/BoyJ</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>M. musculus</italic>, B6)</td><td align="left" valign="bottom">CD45.2</td><td align="left" valign="bottom">Jackson laboratories</td><td align="left" valign="bottom">C57BL/6J</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>, B6)</td><td align="left" valign="bottom"><italic>HSC-SCL-CreER<sup>T</sup>/Confetti</italic></td><td align="left" valign="bottom">Dr. Louise Purton</td><td align="left" valign="bottom">C57BL/6-Tg(Tal1-cre/ERT)42-056Jrg/J and B6.129P2-<italic>Gt(ROSA)26Sor<sup>tm1(CAG-Brainbow2.1)Cle</sup></italic>/J</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>, B6)</td><td align="left" valign="bottom"><italic>Fancc<sup>+/−</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib10">Cerabona et al., 2016</xref>, <xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>, B6)</td><td align="left" valign="bottom">Vav-Cre</td><td align="left" valign="bottom">Dr. Tong Wei</td><td align="left" valign="bottom">B6.Cg-Tg(VAV1-cre)1Graf/MdfJ</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HL-60</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>H. sapiens</italic>)</td><td align="char" char="." valign="bottom">293T</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom"/><td align="left" valign="bottom">To generate lentivirus</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FcBlock (Rat monoclonal, clone 93)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:101320; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1574975">AB_1574975</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-B220 (Rat monoclonal, clone RA3-6B2)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:103212; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312997">AB_312997</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-CD3ε (Armenian Hamster monoclonal, clone 145-2C11)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:100311; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_389300">AB_389300</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-CD11b (Rat monoclonal, clone M1/70)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:101212; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312795">AB_312795</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-Gr-1 (Rat monoclonal, clone RB6-8C5)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:108412; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313377">AB_313377</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-TER119 (Rat monoclonal, clone TER119)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:116212; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313713">AB_313713</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-Ly6C (Rat monoclonal, clone HK 1.4)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:128015; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1732076">AB_1732076</ext-link></td><td align="char" char="." valign="bottom">(1:320)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-CD4 (Rat monoclonal, clone GK1.5)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:100411; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312696">AB_312696</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 700 anti-CD48 (Armenian Hamster monoclonal, clone HM48-1)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:103426; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10612755">AB_10612755</ext-link></td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 700 anti-CD34 (Rat monoclonal, clone RAM34)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat:56-0341-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493998">AB_493998</ext-link></td><td align="char" char="." valign="bottom">(1:40)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 700 anti-NK1.1 (Mouse monoclonal, clone PK136)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:108729; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2074426">AB_2074426</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC/Cyanine7 anti-Sca-1 (Rat monoclonal, clone D7)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:108126; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10645327">AB_10645327</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC/Cyanine7 anti-CD45.2 (Mouse monoclonal, clone 104)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:109824; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_830789">AB_830789</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC/Cyanine7 anti-CD8 (Rat monoclonal, clone 53-6.7)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:100711; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312750">AB_312750</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE/Cyanine7 anti-Sca-1 (Rat monoclonal, clone D7)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:108114; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493596">AB_493596</ext-link></td><td align="char" char="." valign="bottom">(1:800)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE/Cyanine7 anti-Ly6G (Rat monoclonal, clone 1A8)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:127617; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1877261">AB_1877261</ext-link></td><td align="char" char="." valign="bottom">(1:800)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Pacific Blue anti-B220 (Rat monoclonal, clone RA3-6B2)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:103227; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_492876">AB_492876</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Pacific Blue anti-CD3ε (Armenian Hamster monoclonal, clone 145-2C11)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:100334; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2028475">AB_2028475</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP anti-CD11b (Rat monoclonal, clone M1/70)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:101229; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2129375">AB_2129375</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 421 anti-CD135 (Rat monoclonal, clone A2F10)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:135314; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562339">AB_2562339</ext-link></td><td align="char" char="." valign="bottom">(1:40)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 421 anti-CD45.1 (Mouse monoclonal, clone A20)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:110732; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562563">AB_2562563</ext-link></td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 421 anti-CD41 (Rat monoclonal, clone MWRReg30)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:133911; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10960744">AB_10960744</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 510 anti-IA-IE (Rat monoclonal, clone M5/114.152)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:107635; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2561397">AB_2561397</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 605 anti-CD150 (Rat monoclonal, clone TC15-12F12.2)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:115927; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11204248">AB_11204248</ext-link></td><td align="char" char="." valign="bottom">(1:60)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 650 anti-CD45.2 (Mouse monoclonal, clone 104)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:109836; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2563065">AB_2563065</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 711 anti-CD45.1 (Mouse monoclonal, clone A20)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:110739; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2562605">AB_2562605</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 711 anti-CD150 (Rat monoclonal, clone TC15-12F12.2)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:115941; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629660">AB_2629660</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 711 anti-CD16/32 (Rat monoclonal, clone 93)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:101337; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565637">AB_2565637</ext-link></td><td align="char" char="." valign="bottom">(1:320)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 711 anti-B220 (Rat monoclonal, clone RA3-6B2)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:103255; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2563491">AB_2563491</ext-link></td><td align="char" char="." valign="bottom">(1:160)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 785 anti-CD127 (Rat monoclonal, clone A7R34)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:135037; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565269">AB_2565269</ext-link></td><td align="char" char="." valign="bottom">(1:80)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 785 anti-CD11c (Armenian Hamster monoclonal, clone N418)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:117335; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11219204">AB_11219204</ext-link></td><td align="char" char="." valign="bottom">(1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BUV395 Anti-Mouse CD117 (Rat monoclonal, clone 2B8)</td><td align="left" valign="bottom">BD Horizon</td><td align="left" valign="bottom">Cat:564011; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2738541">AB_2738541</ext-link></td><td align="left" valign="bottom">Dilution depends on experiment, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGK-BFP</td><td align="left" valign="bottom">GenScript</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For producing lentivirus to infect HL-60</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">LeGO-V2</td><td align="left" valign="bottom">Dr. Stefano Rivella lab</td><td align="left" valign="bottom"/><td align="left" valign="bottom">For producing lentivirus to infect HL-60</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mScl/Tal1 F</td><td align="left" valign="bottom">Dr. Louise Purton</td><td align="left" valign="bottom">HSC-SCL-Cre-Genotyping primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CAACAACAACCGGGTGAAGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">1260_1 (TACONIC ctrl)</td><td align="left" valign="bottom">Dr. Louise Purton</td><td align="left" valign="bottom">HSC-SCL-Cre-Genotyping primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GAGACTCTGGCTACTCATCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mx-Cre JH43 (Cre spec.)</td><td align="left" valign="bottom">Dr. Louise Purton</td><td align="left" valign="bottom">HSC-SCL-Cre-Genotyping primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CTTGCACCATGCCGCCCACGAC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">1260_2 (TACONIC ctrl)</td><td align="left" valign="bottom">Dr. Louise Purton</td><td align="left" valign="bottom">HSC-SCL-Cre-Genotyping primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CCTTCAGCAAGAGCTGGGGAC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="char" char="." valign="bottom">1341 (Tg F)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom"><italic>Confetti</italic> mouse genotyping primers</td><td align="left" valign="bottom">GAA TTA ATT CCG GTA TAA CTT CG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">oIMR8545 (WT F)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom"><italic>Confetti</italic> mouse genotyping primers</td><td align="left" valign="bottom">AAA GTC GCT CTG AGT TGT TAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">oIMR8916 (common)</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom"><italic>Confetti</italic> mouse genotyping primers</td><td align="left" valign="bottom">CCA GAT GAC TAC CTA TCC TC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Ref 43, <xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref></td><td align="left" valign="bottom">Fancc-Genotyping primers</td><td align="left" valign="bottom">GAG GAA ACG CCA CAT TTC AG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mutant</td><td align="left" valign="bottom">Ref 43, <xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref></td><td align="left" valign="bottom">Fancc-Genotyping primers</td><td align="left" valign="bottom">ACG AGA TCA GCA GCC TCT GT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Common Reverse</td><td align="left" valign="bottom">Ref 43, <xref ref-type="bibr" rid="bib11">Chen et al., 1996</xref></td><td align="left" valign="bottom">Fancc-Genotyping primers</td><td align="left" valign="bottom">AGG TCT GGA GAA ATG GCT CA</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">EasySep Mouse Hematopoietic Progenitor Cell Isolation Kit</td><td align="left" valign="bottom">StemCell Technologies</td><td align="left" valign="bottom">Cat:19856</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">5-FU (Fluorouracil)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">SKU: PHR1227-500MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI (4′,6-Diamidino-2-Phenylindole, Dilactate)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat:422801</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 9</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo v10</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.flowjo.com/solutions/flowjo</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R studio</td><td align="left" valign="bottom">Posit Software</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://posit.co/download/rstudio-desktop/">https://posit.co/download/rstudio-desktop/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R code to analyze all the data</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.8222789">https://doi.org/10.5281/zenodo.8222789</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97504.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Cambridge</institution><country>United Kingdom</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study by Liu and colleagues uses lineage tracing of hematopoietic stem and progenitor cells in situ to infer the clonal dynamics of adult hematopoiesis. The authors apply a new mathematical analysis framework enabling a wider range of clonal estimation and the revised study (1) provides evidence of polyclonal adult hematopoiesis, (2) provides insights on clonal dynamics during fetal liver hematopoiesis, and (3) reveals unexpectedly high polyclonality in a mouse model of bone marrow failure (Fanconi anemia), arguing against the prevalent views of clonal attrition in this context. The evidence in this extensively revised and improved study is <bold>compelling</bold>, with methods, data and analyses more rigorous than the current state-of-the-art, which will be of broad interest not only to stem cell and developmental biologists working on hematopoiesis, but also to researchers working on other systems.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97504.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Previous studies have used a randomly induced label to estimate the number of hematopoietic precursors that contribute to hematopoiesis. In particular, the McKinney-Freeman lab established a measurable range of precursors of 50-2500 cells using random induction of one of the 4 fluorescent proteins (FPs) of a Confetti reporter in the fetal liver to show that hundreds of precursors establish lifelong hematopoiesis. In the presented work, Liu and colleagues aim to extend the measurable range of precursor numbers previously established and enable measurement in a variety of contexts beyond embryonic development. To this end, the authors investigated whether the random induction of a given Confetti FP follows the principles of binomial distribution such that the variance inversely correlates with the precursor number. The authors validated their hypothesis and identified sampling conditions to minimize experimental error using a simplified in vitro system. They use tamoxifen-inducible Scl-CreER, active in hematopoietic stem and progenitor cells (HSPCs), to induce Confetti labeling and investigate whether they could extend their model to cell numbers below 50 with in vivo transplantation of high versus low numbers of Confetti total bone marrow (BM) cells. The data generated are generally robust. While the lower and upper limits of the model may show some small error or have not yet been completely validated experimentally, it extends the measurable range of precursor from 15 - 10^5 cells. The authors then apply their model to estimate the number of hematopoietic precursors that contribute to hematopoiesis in a variety of contexts including adult steady state, fetal liver, following myeloablation, and a genetic model of Fanconi anemia.</p><p>Their data highlight the importance of estimating precursor numbers and not just donor frequency in transplantation settings and show that native hematopoiesis is highly polyclonal. Their data also confirm previous findings from Ganuza et al, 2022 that demonstrate no major expansion of precursors between E11.5 - E14.5. Finally, their work reveals intact Fancc-/-precursor numbers following transplantation, suggesting that the observed reduced chimerism is due to defects in cell proliferation.</p><p>The conclusions are generally sound and based on high-quality data. As the authors note, future studies should validate the model using alternative Cre-drivers to exclude any potential functional difference between labelled and non-labelled cells. Although this system does not permit tracing of individual clones, the modeling presented allows measurements of clonal activity covering nearly the entire HSPC population (as recently estimated by Cosgrove et al, 2021) and can be applied to a wide range of in vivo contexts with relative ease.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97504.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The manuscript is well written, with beautiful and clear figures, and both methods and mathematical models are clear and easy to understand. Since 2017, Mikel Ganuza, Shannon McKinney-Freeman et al have been using these Confetti approaches that rely on calculating the variance across independent biological replicates as a way to infer clonal dynamics. This is a powerful tool and it is a pleasure to see it being implemented in more labs around the world. One of the cool novelties of the current manuscript is using a mathematical model (based on a binomial distribution) to avoid directly regressing the Confetti labeling variance with the number of clones (which only has linearity for a small range of clone numbers). As a result, this current manuscript of Liu et al. methodologically extends the usability of the Confetti approach, allowing them more precise and robust quantification.</p><p>They then use this model to revisit some questions from various Ganuza et al. papers, validating most of their conclusions. The application to the clonal dynamics of hematopoiesis in a model of Fanconi anemia (Fancc mice) is very much another novel aspect, and shows the surprising result that clonal dynamics are remarkably similar to the wild-type (in spite of the defect that these Fancc HSCs have during engraftment).</p><p>Overall, the manuscript succeeds at what it proposes to do, stretching out the possibilities of this Confetti model, which I believe will be useful for the entire community of stem cell biologists, and possibly make these assays available to other stem cell regenerating systems.</p><p>The revised version has incorporated the reviewer suggestions, strengthening the solidity of the arguments and statements, and highlighting alternative interpretations. My comments were addressed in full.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97504.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The paper presents a solid method for quantifying hematopoietic precursors using statistical variance as a proxy, providing valuable insights into hematopoietic dynamics across different physiological and pathological scenarios. The findings are pivotal for understanding hematopoietic dynamics. The strength of the evidence is convincing and acknowledges limitations such as the binomial assumption and the need of tools to measure clonality.</p><p>Liu et al. focus on a mathematical method to quantify active hematopoietic precursors in mice using Confetti reporter mice combined with Cre-lox technology. The paper explores the hematopoietic dynamics in various scenarios, including homeostasis, myeloablation with 5-fluorouracil, Fanconi anemia (FA), and post-transplant environments. The key findings and strengths of the paper include (1) precursor quantification: The study develops a method based on the binomial distribution of fluorescent protein expression to estimate precursor numbers. This method is validated across a wide dynamic range, proving more reliable than previous approaches that suffered from limited range and high variance outside this range; (2) dynamic response analysis: The paper examines how hematopoietic precursors respond to myeloablation and transplantation; (3) application in disease models: The method is applied to the FA mouse model, revealing that these mice maintain normal precursor numbers under steady-state conditions and post-transplantation, which challenges some assumptions about FA pathology. Despite the normal precursor count, a diminished repopulation capability suggests other factors at play, possibly related to cell proliferation or other cellular dysfunctions. In addition, the FA mouse model showed a reduction in active lymphoid precursors post-transplantation, contributing to decreased repopulation capacity as the mice aged. The authors are aware of the limitation of the assumption of uniform expansion. The paper assumes a uniform expansion from active precursor to progenies for quantifying precursor numbers. This assumption may not hold in all biological scenarios, especially in disease states where hematopoietic dynamics can be significantly altered. If non-uniformity is high, this could affect the accuracy of the quantification. Overall, the study underscores the importance of precise quantification of hematopoietic precursors in understanding both normal and pathological states in hematopoiesis, presenting a robust tool that could significantly enhance research in hematopoietic disorders and therapy development. This manuscript would be interesting to the readers of eLife.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97504.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Suying</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>Sarah E</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Haotian</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ehnot</surname><given-names>Juliana</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Seul K</given-names></name><role specific-use="author">Author</role><aff><institution>Children's Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Jeffrey</surname><given-names>Greer</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Menna</surname><given-names>Theresa</given-names></name><role specific-use="author">Author</role><aff><institution>Children&amp;apos;s Hospital of Philadelphia</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Purton</surname><given-names>Louise</given-names></name><role specific-use="author">Author</role><aff><institution>St. Vincent's Institute of Medical Research</institution><addr-line><named-content content-type="city">Fitzroy</named-content></addr-line><country>Australia</country></aff></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Hongzhe</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kurre</surname><given-names>Peter</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Previous studies have used a randomly induced label to estimate the number of hematopoietic precursors that contribute to hematopoiesis. In particular, the McKinneyFreeman lab established a measurable range of precursors of 50-2500 cells using random induction of one of the 4 fluorescent proteins (FPs) of a Confetti reporter in the fetal liver to show that hundreds of precursors establish lifelong hematopoiesis. In the presented work, Liu and colleagues aim to extend the measurable range of precursor numbers previously established and enable measurement in a variety of contexts beyond embryonic development. To this end, the authors investigated whether the random induction of a given Confetti FP follows the principles of binomial distribution such that the variance inversely correlates with the precursor number. They tested their hypothesis using a simplified 2-color in vitro system, paying particular attention to minimizing sources of experimental error (elimination of outliers, sample size, events recorded, etc.) that may obscure the measurement of variance. As a result, the data generated are robust and show that the measurable range of precursors can be extended up to 105 cells. They use tamoxifen-inducible Scl-CreER, which is active in hematopoietic stem and progenitor cells (HSPCs) to induce Confetti labeling, and investigated whether they could extend their model to cell numbers below 50 with in vivo transplantation of high versus low numbers of Confetti total bone marrow (BM) cells. The premise of binomial distribution requires that the number of precursors remains constant within a group of mice. The rare frequency of HSPCs in the BM means that the experimentally generated &quot;low&quot; number recipient animals showed some small variability of seeding number, which does not follow the requirement for binomial distribution. While variance due to differences in precursor numbers still dominates, it is unclear how accurate estimated numbers are when precursor numbers are low (&lt;10).</p></disp-quote><p>According to our simulation, the differences between estimated numbers and the corresponding expected numbers are more profound at numbers below 10, but they are still relatively small. Since Figure S4A is in log-scale, it might be difficult for readers to appreciate the magnitude in difference from the graph. We plan to add a linear scale figure to Figure S4A for better visualization of the absolute value differences (left). We also plan to provide an additional graph quantifying the value differences between estimated and expected values for numbers below 15 (right). From both graphs, the maximum difference between estimated n and expected n occurs at 10 precursor numbers (estimated as 7.6). We admit that these numbers are not numerically the same, and some minor correction of the formula may be needed if a very accurate absolute number is warrant. However, we also want to emphasize that 1. most estimated n values are within 25% range of the expected n; 2. despite the minor discrepancy, the estimated n is still highly correlated with the expected n, so the comparison between different precursor numbers was not affected.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>The authors then apply their model to estimate the number of hematopoietic precursors that contribute to hematopoiesis in a variety of contexts including adult steady state, fetal liver, following myeloablation, and a genetic model of Fanconi anemia. Their modeling shows:</p><p>- thousands of precursors (~2400-2600) contribute to adult myelopoiesis, which is in line with results from a previous study (Sun et al, 2014).</p><p>- myeloablation (single dose 5-FU), while reducing precursor numbers of myeloid progenitors and HSPCs, was not associated with a reduction in precursor numbers of LTHSCs.</p><p>- no major expansion of precursor number in the fetal liver derived from labeling at E11.5 versus E14.5, consistent with recent findings from Ganuza et al, 2022.</p><p>- normal precursor numbers in Fancc-/- mice at steady state and from competitive transplantation of young Fancc-/- BM cells, suggesting that reduced Fancc-/- cell proliferation may underlie the reduced chimerism upon transplantation.</p><p>- reduced number of lymphoid precursors following transplantation of BM cells from 9month-old Fancc-/- animals (beyond this age animals have decreased survival).</p><p>Although this system does not permit the tracing of individual clones, the modeling presented allows measurements of clonal activity covering nearly the entire HSPC population (as recently estimated by Cosgrove et al, 2021) and can be applied to a wide range of in vivo contexts with relative ease. The conclusions are generally sound and based on high-quality data. Nevertheless, some results could benefit from further explanation or discussion:</p><p>- The estimated number of LT-HSCs that contribute to myelopoiesis is not specifically provided, but from the text, it would be calculated to be 1958/5 = ~391. Data from Busch et al, 2015 suggest that the number of differentiation-active HSCs is 5.2x103, which is considered the maximum limit. There is nevertheless a more than 10-fold difference between these two estimates, and it is unclear how this discrepancy arises.</p></disp-quote><p>First, we would like to clarify a sentence in the manuscript.</p><p>“The average myeloid precursor number at the time of BM analysis (1958) matched the average precursor number calculated from BM myeloid progenitors (MP, Lin-Sca-1-cKit+) and HSPCs (1773 and 1917), but it was five-fold higher than that of LT-HSC (Figure 3E).”</p><p>In this sentence, we compared the number of precursors calculated from peripheral blood myeloid cells to the those calculated from BM myeloid progenitor, HSPC and LT-HSC. However, we did not intend to imply that those precursors numbers calculated from HSPC and LT-HSC specifically contribute to myelopoiesis. To avoid misunderstanding, we propose to change this sentence to read:</p><p>“The average precursor number calculated from PB myeloid cells at the time of BM analysis (1958) matched those calculated from BM myeloid progenitors (MP, Lin-Sca-1-cKit+) and HSPCs (1773 and 1917), but it was fivefold higher than that of LT-HSC (Figure 3E).”</p><p>Nonetheless, we appreciate the reviewers’ comment on the gap between the precursor numbers of LT-HSC and the number of differentiation-active HSCs reported in Busch et al, 2015. We propose the following explanation:</p><p>First of all, precursor numbers reflect LT-HSC self-renewal by symmetric division and maintenance by asymmetric division but not differentiation. To compare the number of differentiation-active LT-HSC, precursor numbers measured from differentiated progeny (progenitors) is a better choice. As our system does not differentiate the origin of a precursor, measuring the precursor number of differentiation-active LT-HSC is difficult, since progenitors may also derive from other long-lived MPPs. However, if we assume that most divisions of LT-HSC are asymmetric division, generating one LT-HSC and one progenitor, then we can approximate the number of differentiation-active HSCs with the precursor numbers of LT-HSC.</p><p>Second, when Busch et al, 2015 calculated the number of differentiation-active HSC, they measured the cumulative activity of stem cells by following the mice up to 36 weeks postinduction. Our method measured the recent but not accumulative activity of HSC, thus the number of differentiation-active HSC in Busch et al 2015 is predicted to be higher.</p><p>Third, Busch et al, 2015 used Tie2MCM Cre to trace HSC. It has been shown that Tie2+ HSC have a higher reconstitution capacity (Ito et al 2016, Science), but no one has compared the <italic>in situ</italic> activity of Tie2+ and Tie2- HSC in a native environment. Since the behavior of HSCs <italic>in situ</italic> may be very different from their behavior in a transplantation setting, it is possible that Tie2+ HSC are more prone to differentiation than Tie2- HSC in a native environment, leading to an overestimation of differentiation-active HSC in the HSC pool.</p><disp-quote content-type="editor-comment"><p>- Similarly, in Figure 3E, the estimated number of precursors is highest in MPP4, a population typically associated with lymphoid potential and transient myeloid potential, whereas the numbers of MPP3, traditionally associated with myeloid potential, tend to be higher but are not significantly different than those found in HSCs.</p></disp-quote><p>We believe this question results from similar confusion of the nomenclature of myeloid precursors in the previous question. As explained previously, the precursors quantified reflect a variety of possible differentiation routes, not just myelopoiesis. Thus, Figure 3E did not suggest that the lymphoid-biased MPP4 has more myeloid precursors than LTHSC. Instead, it simply means more precursors contribute to MPP4 population than the LT-HSC pool. We apologize for the confusion.</p><disp-quote content-type="editor-comment"><p>- The requirement for estimating precursor numbers at stable levels of Confetti labeling is not well explained. As a result, it is unclear how accurate the estimates of B cell precursors upon transplantation of Fancc-/- cells are. In previous experiments on normal Confetti mice (Figure 3B), the authors do not estimate precursors of lymphopoiesis because Confetti labeling of B cells is not saturated, and this appears to be the case in Fanc-/- animals as well (Fig. 5B).</p></disp-quote><p>We appreciate the request for clarification. Our approach required the labeling level to be stable in peripheral blood because we calculate the total number of precursors by normalizing precursor numbers in Confetti+ population with the labeling level (precursor numbers in Confetti+ population divided by labeling efficiency). If the labeling level is not saturated, then the calculation of total precursors will be overestimated. This requirement is more important in native hematopoiesis, since it takes a long time for the mature population, especially the lymphoid population, to be fully replaced by the progenies from the labeled HSPC population (as suggested by Busch et al 2015 and Säwen et al 2018). In transplantation, since lethal irradiation was performed, mature blood cells were rapidly generated by HSPCs, thus saturation of labeling level is not a major concern for precursor quantification. We plan to add Author response image 2 as evidence that Confetti labeling level was stable in mice transplanted with <italic>Fancc-/-</italic> cells.</p><fig id="sa4fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-sa4-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>- Do 9-month-old Fanc-/- animals have reduced lymphoid precursors as well?</p></disp-quote><p>Because of the non-saturated labeling in peripheral blood B cells and extra-HSPC induction of Confetti in T cells, we cannot accurately measure lymphoid precursor numbers in 9-month-old <italic>Fancc-/-</italic> animals. As an alternative, the precursor number of lymphoid biased MPP4 population were comparable between <italic>Fancc+/+</italic> and <italic>Fancc-/-</italic> animals (Figure 5D). We plan to add the frequency of common lymphoid progenitors (defined by Lin-IL-7Ra+Sca-1midcKitmid) add a supplementary figure to show were CLP frequencies between these two genotypes.</p><fig id="sa4fig3" position="float"><label>Author response image 3.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-sa4-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>This manuscript by Liu et al. uses Confetti labeling of hematopoietic stem and progenitor cells in situ to infer the clonal dynamics of adult hematopoiesis. The authors apply a new mathematical framework to analyze the data, allowing them to increase the range of applicability of this tool up to tens of thousands of precursors. With this tool, they (1) provide evidence for the large polyclonality of adult hematopoiesis, (2) offer insights on the expansion dynamics in the fetal liver stage, (3) assess the clonal dynamics in a Fanconi anemia model (Fancc), which has engraftment defects during transplantation.</p><p>Strengths:</p><p>The manuscript is well written, with beautiful and clear figures, and both methods and mathematical models are clear and easy to understand.</p><p>Since 2017, Mikel Ganuza and Shannon McKinney-Freeman have been using these Confetti approaches that rely on calculating the variance across independent biological replicates as a way to infer clonal dynamics. This is a powerful tool and it is a pleasure to see it being implemented in more labs around the world. One of the cool novelties of the current manuscript is using a mathematical model (based on a binomial distribution) to avoid directly regressing the Confetti labeling variance with the number of clones (which only has linearity for a small range of clone numbers). As a result, this current manuscript of Liu et al. methodologically extends the usability of the Confetti approach, allowing them more precise and robust quantification.</p><p>They then use this model to revisit some questions from various Ganuza et al. papers, validating most of their conclusions. The application to the clonal dynamics of hematopoiesis in a model of Fanconi anemia (Fancc mice) is very much another novel aspect, and shows the surprising result that clonal dynamics are remarkably similar to the wild-type (in spite of the defect that these Fancc HSCs have during engraftment).</p><p>Overall, the manuscript succeeds at what it proposes to do, stretching out the possibilities of this Confetti model, which I believe will be useful for the entire community of stem cell biologists, and possibly make these assays available to other stem cell regenerating systems.</p><p>Weaknesses:</p><p>My main concern with this work is the choice of CreER driver line, which then relates to some of the conclusions made. Scl-CreER succeeds at being as homogenous as possible in labeling HSC/MPPs... however it is clear that it also labels a subcompartment of HSC clones that become dominant with time... This is seen as the percentage of Confettirecombined cells never ceases to increase during the 9-month chase of labeled cells, suggesting that non-labeled cells are being replaced by labeled cells. The reason why this is important is that then one cannot really make conclusions about the clonal dynamics of the unlabeled cells (e.g. for estimating the total number of clones, etc.).</p></disp-quote><p>We appreciate the reviewers’ comments. We also agree that this is especially a concern for measuring B cell precursors in native hematopoiesis. For myeloid cells, the increase was much less profound (0.5% per month) after month four post-induction. One way to investigate the dynamics of unlabeled cells is to induce different groups of mice with different doses of tamoxifen so that labeling efficiency varies among different groups. With 14 days of tamoxifen treatment, maximum 60% of HSPC can be labeled (RFP+CFP+YFP). If the unlabeled cells behave similarly with labeled cells, then varying the labeling efficiency shouldn’t affect the total number of precursors calculated (if excluding the potential effect of longer tamoxifen treatment on HSC). While we haven’t extensively performed such lengthy experiment, we have performed one measurement (5 mice) with 14-days of tamoxifen treatment and showed that peripheral blood myeloid precursor numbers calculated from this experiment were comparable to the ones from Figure 3 (2-day tamoxifen).</p><fig id="sa4fig4" position="float"><label>Author response image 4.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97504-sa4-fig4-v1.tif"/></fig><p>It's possible that those HSPC that are never labeled with Confetti even during longer tamoxifen treatment could behave differently. In this case, a different Cre driver may provide insight into the total precursor numbers.</p><disp-quote content-type="editor-comment"><p>I am not sure about the claims that the data shows little precursor expansion from E11 to E14. First, these experiments are done with fewer than 5 replicates, and thus they have much higher error, which is particularly concerning for distinguishing differences of such a small number of clones. Second, the authors do see a ~0.5-1 log difference between E11 and E14 (when looking at months 2-3). When looking at months 5+, there is already a clear decline in the total number of clones in both adult-labeled and embryonic-labeled, so these time points are not as good for estimating the embryonic expansion. In any case, the number of precursors at E11 (which in the end defines the degree of expansion) is always overestimated (and thus, the expansion underestimated) due to the effects of lingering tamoxifen after injection (which continues to cause Confetti allele recombination as stem cell divide). Thus, I think these results are still compatible with expansion in the fetal liver (the degree of which still remains uncertain to me).</p></disp-quote><p>We agreed adding additional replicates will reducing any error and boost confidence in our conclusions. The dilemma of comparing fetal- and adult-labeled cohorts is that HSPC activities could not be synchronized among different developmental stages. At fetal to neonatal stage, HSPC proliferate faster to generate new blood cells and support developmental need, while at adult stage HSPC proliferate much slower. Thus, it takes long time for the mature myeloid cells in the adult-labeled cohort to reach a stable Confetti labeling and provide an accurate quantification of precursor. While we agree that it might be better to compare precursor numbers in earlier months, we preferred to compare precursor numbers at later time points for the aforementioned reasons. The other option is to compare the number of HSPC precursors in the BM at earlier time points, as no equilibration of labeling level is required in HSPC, but this requires earlier sacrifice, compromising long term assessment.</p><p>We did not revisit questions about the lingering effect of tamoxifen, as this has been studied by Ganuza et al 2017. They showed that tamoxifen was not able to induce additional Confetti recombination if given one day ahead, suggesting the effective window for tamoxifen is less than 24h.</p><p>Based on our data, the expansion of lifelong precursors range anywhere from 1.4 to 7.0 (Figure 4G). It’s possible that we might observe a higher level of expansion if the comparison was done in earlier time points. Nonetheless, the assertion that the expansion of life-long HSPC is not as profound as evidenced by transplantation, emphasizes value of HSPC activity analysis <italic>in situ</italic>.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>Liu et al. focus on a mathematical method to quantify active hematopoietic precursors in mice using Confetti reporter mice combined with Cre-lox technology. The paper explores the hematopoietic dynamics in various scenarios, including homeostasis, myeloablation with 5-fluorouracil, Fanconi anemia (FA), and post-transplant environments. The key findings and strengths of the paper include (1) precursor quantification: The study develops a method based on the binomial distribution of fluorescent protein expression to estimate precursor numbers. This method is validated across a wide dynamic range, proving more reliable than previous approaches that suffered from limited range and high variance outside this range; (2) dynamic response analysis: The paper examines how hematopoietic precursors respond to myeloablation and transplantation; (3) application in disease models: The method is applied to the FA mouse model, revealing that these mice maintain normal precursor numbers under steady-state conditions and posttransplantation, which challenges some assumptions about FA pathology. Despite the normal precursor count, a diminished repopulation capability suggests other factors at play, possibly related to cell proliferation or other cellular dysfunctions. In addition, the FA mouse model showed a reduction in active lymphoid precursors post-transplantation, contributing to decreased repopulation capacity as the mice aged. The authors are aware of the limitation of the assumption of uniform expansion. The paper assumes a uniform expansion from active precursor to progenies for quantifying precursor numbers. This assumption may not hold in all biological scenarios, especially in disease states where hematopoietic dynamics can be significantly altered. If non-uniformity is high, this could affect the accuracy of the quantification. Overall, the study underscores the importance of precise quantification of hematopoietic precursors in understanding both normal and pathological states in hematopoiesis, presenting a robust tool that could significantly enhance research in hematopoietic disorders and therapy development. The following concerns should be addressed.</p><p>Major Points:</p><p>• The authors have shown a wide range of seeded cells (1 to 1e5) (Figure 1D) that follow the linear binomial rule. As the standard deviation converges eventually with more seeded cells, the authors need to address this limitation by seeding the number of cells at which the assumption fails.</p></disp-quote><p>While number range above 105 is not required for our measurement of hematopoietic precursors in mice, we agree that it will be valuable to understand the upper limit of experimental measurement. we plan to seed 106-107 cells per replicate to address reviewer’s comments.</p><disp-quote content-type="editor-comment"><p>• Line 276: This suggests myelopoiesis is preferred when very few precursors are available after irradiation-mediated injury. Did the authors see more myeloid progenitors at 1 month post-transplantation with low precursor number? The authors need to show this data in a supplement.</p></disp-quote><p>While we appreciate the concern, we did not generate this dataset because this requires take down of a substantial number of animals at one-month post-transplantation.</p><disp-quote content-type="editor-comment"><p>Minor Points:</p><p>• Please cite a reference for line 40: a rare case where a single HSPC clone supports hematopoiesis.</p><p>• Line 262-263: &quot;This discrepancy may reflect uneven seeding of precursors to the BM throughout the body after transplantation and the fact that we only sampled a part of the BM (femur, tibia, and pelvis).&quot; Consider citing this paper (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2023.09.019">https://doi.org/10.1016/j.cell.2023.09.019</ext-link>) that explores the HSPCs migration across different bones.</p><p>• Lines 299 and 304. Misspellings of RFP.</p></disp-quote><p>We appreciate reviewer’s suggestions and will modify as suggested.</p><disp-quote content-type="editor-comment"><p>• The title is misleading as the paper's main focus is the precursor number estimator using the binomial nature of fluorescent tagging. Using a single-copy cassette of Confetti mice cannot be used to measure clonality.</p></disp-quote><p>We appreciate reviewer’s suggestions and plan to modify the title of the manuscript to read: “Dynamic Tracking of Native Precursors in Adult Mice”.</p></body></sub-article></article>